{
  "data": [
    [
      "Ribavirin",
      "-",
      "109.5",
      "-",
      ">400",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Nafamostat",
      "Buipel",
      "22.5",
      "-",
      ">100",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Penciclovir",
      "-",
      "95.96",
      "-",
      ">400",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Nitazoxanide",
      "-",
      "2.12",
      "-",
      "35.53",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Chloroquine",
      "-",
      "1.13",
      "-",
      ">100",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Remdesivir ",
      "GS5734",
      "0.77",
      "-",
      ">100",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Favipiravir",
      "T-705",
      "61.88",
      "-",
      ">400",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41422-020-0282-0"
    ],
    [
      "Camostat",
      "Camostat Mesilate, FOY-305, Foipan, Camostat Mesylate",
      "-",
      "Active",
      "-",
      "Munich 929 ",
      "Calu-3",
      "0.001",
      "RT-qPCR",
      "CellTiter-Glo Luminescent CellViability Assay (Promega)",
      "https://doi.org/10.1016/j.cell.2020.02.052"
    ],
    [
      "HydroxyChloroquine",
      "Quensyl, Plaquenil, Hydroquin, Dolquine, Quinoric",
      "0.72",
      "-",
      "-",
      "C-Tan-nCoV Wuhan strain 01",
      "Vero",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1093/cid/ciaa237"
    ],
    [
      "Chloroquine",
      "Resochi",
      "5.47",
      "-",
      "-",
      "C-Tan-nCoV Wuhan strain 01",
      "Vero",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1093/cid/ciaa237"
    ],
    [
      "Apilimod",
      "-",
      "0.023",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "Z LVG- CHN2",
      "-",
      "0.19",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "MDL 28170",
      "-",
      "0.22",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "VBY-825",
      "-",
      "~0.3",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "ONO 5334",
      "-",
      "~0.5",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "Remdesivir ",
      "-",
      "0.62",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "AMG-2674",
      "-",
      "~0.95",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "HanfangchiA",
      "-",
      "~1.1",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "YH-1238",
      "-",
      "~0.95",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "MLN-3897",
      "-",
      "0.14",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "SDZ-62-434",
      "-",
      "0.75",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "SB-616234-A",
      "-",
      "~1.2",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "8(3-chlorostyryl)caffeine",
      "-",
      "1.6",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "N-tert-Butylisoquine",
      "-",
      "~1.2",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "SL-11128",
      "-",
      "~0.25",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "Elopiprazole",
      "-",
      "~1.1",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "Astemizole",
      "-",
      "~1.1",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "KW8232",
      "-",
      "~1.2",
      "-",
      "-",
      "USA-WA1/2020 patient derived",
      "Vero E6",
      "0.75",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.04.16.044016 "
    ],
    [
      "1-Deoxynojirimycin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "4E1RCat",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "4E2RCat",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "4EGI-1",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "4EGI-1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "ABBV-744",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "ABBV-744",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "AC-55541",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "AC-55541",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Apicidin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Apicidin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "AZ3451",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "AZ3451",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Azithromycin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Bafilomycin A1",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Bafilomycin A1",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "BD1008",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Camostat",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Camostat",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Captopril",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Captopril",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Carbapentane",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "CB5083",
      "-",
      "-",
      "Agonist",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Chloramphenicol",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Clemastine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Clemastine",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Cloperastine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Cloperastine",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "CPI-0610",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "CPI-0610",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Daunorubicin",
      "-",
      "-",
      "Agonist",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Daunorubicin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "DBeQ",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "dBET6",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "dBET6",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Dextromethorphan",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Dextromethorphan",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "E-52862",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "E-52862",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "H-89",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "H-89",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Haloperidol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Haloperidol",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ifenprodil",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Indomethacin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Indomethacin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "JQ1",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "JQ1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Lisinopril",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Lisinopril",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Loratadine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Loratadine",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Lovastatin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Luminespib",
      "-",
      "-",
      "U-shaped response",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Merimepodib",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Merimepodib",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Metformin",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Metformin",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Midostaurin",
      "-",
      "-",
      "Agonist",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Midostaurin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Minoxidil",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "ML240",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "ML240",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Mycophenolic Acid",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Mycophenolic Acid",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "MZ1",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "MZ1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Nafamostat",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Nafamostat",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Nitazoxanide",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Olanzapine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Onalespib",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Pazopanib",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Pazopanib",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PB28",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PB28",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PD-144418",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PD-144418",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Pepstatin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PF-846",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PF-846",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Pimozide",
      "-",
      "-",
      "Inactive/Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Pioglitazone",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ponatinib",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ponatinib",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Progesterone",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PS3061",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "PS3061",
      "-",
      "-",
      "Inconclusive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Quercetin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "RapaLink-1",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Rapamycin",
      "Sirolimus",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Rapamycin",
      "Sirolimus",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ribavirin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ribavirin",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Rimcazole",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Brivudine",
      "RP101",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Brivudine",
      "RP101",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "RS-PPCC",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "RS-PPCC",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ruxolitinib",
      "-",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ruxolitinib",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "RVX-208",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "RVX-208",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Sapanisertib",
      "INK128, MlN128",
      "-",
      "Inconclusive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Sapanisertib",
      "INK128, MlN128",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Silmitasertib",
      "CX-4945",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Siramesine",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "S-verapamil",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "S-verapamil",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ternatin 4",
      "DA3",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Ternatin 4",
      "DA3",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Tomivosertib",
      "eFT-508",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Tomivosertib",
      "eFT-508",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Valproic Acid",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Valproic Acid",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "XL413",
      "-",
      "-",
      "Inactive",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Zotatifin",
      "eFT226",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.025",
      "Immunofluorescence/TCID50",
      "MTT assay (Roche)",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "Zotatifin",
      "eFT226",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Plaque assay",
      "Alamar Blue",
      "https://doi.org/10.1038/s41586-020-2286-9"
    ],
    [
      "N3",
      "-",
      "16.77",
      "-",
      "133",
      "Patient Isolate",
      "Vero E6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1038/s41586-020-2223-y"
    ],
    [
      "Ebselen",
      "-",
      "4.67",
      "-",
      "-",
      "Patient Isolate",
      "Vero E6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1038/s41586-020-2223-y"
    ],
    [
      "Cinanserin",
      "-",
      "20.61",
      "-",
      ">200",
      "Patient Isolate",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1038/s41586-020-2223-y"
    ],
    [
      "Abemaciclib",
      "-",
      "6.62",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Abemaciclib",
      "-",
      "43.7",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Amodiaquine Dihydrochloride 5.15",
      "-",
      "5.15",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Amodiaquine Dihydrochloride 5.15",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Anidulafungin",
      "-",
      "4.64",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Anidulafungin",
      "-",
      "17.23",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Bazedoxifene",
      "-",
      "3.44",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Bazedoxifene",
      "-",
      "12.63",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Berbamine Hydrochloride",
      "-",
      "7.87",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Berbamine Hydrochloride",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Cepharanthine",
      "-",
      "4.47",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Cepharanthine",
      "-",
      "30",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Chloroquine",
      "-",
      "7.28",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Chloroquine",
      "-",
      "69.2",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Ciclesonide",
      "-",
      "4.33",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Ciclesonide",
      "-",
      "10.6",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Cyclosporine",
      "-",
      "5.82",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Cyclosporine",
      "-",
      "4.69",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Digitoxin",
      "-",
      "0.23",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Digitoxin",
      "-",
      "0.16",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Digoxin",
      "-",
      "0.19",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Digoxin",
      "-",
      "0.72",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Eltrombopag",
      "-",
      "8.27",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Eltrombopag",
      "-",
      "8.38",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Gilteritinib",
      "-",
      "6.76",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Gilteritinib",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Hexachlorophene",
      "-",
      "0.9",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Hexachlorophene",
      "-",
      "1.48",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Hydroxyprogesterone Caproate",
      "-",
      "6.3",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Hydroxyprogesterone Caproate",
      "-",
      "3.87",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Ivacaftor",
      "-",
      "6.57",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Ivacaftor",
      "-",
      "11.55",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Loperamide Hydrochloride",
      "-",
      "9.27",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Loperamide Hydrochloride",
      "-",
      "12.53",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Lopinavir",
      "-",
      "9.12",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Lopinavir",
      "-",
      "21.7",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Mefloquine",
      "-",
      "4.33",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Mefloquine",
      "-",
      ">50",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Nafamostat Mesylate",
      "-",
      "0.0022",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Nafamostat Mesylate",
      "-",
      "13.88",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Niclosamide",
      "-",
      "0.28",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Niclosamide",
      "-",
      "0.84",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Ouabain",
      "-",
      "<0.1 ",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Ouabain",
      "-",
      "<0.1",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Oxyclozanide",
      "-",
      "3.71",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Oxyclozanide",
      "-",
      "6.78",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Proscillaridin",
      "-",
      "2.04",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Proscillaridin",
      "-",
      "5.95",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Remdesivir",
      "-",
      "1.3",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Remdesivir",
      "-",
      "11.41",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Salinomycin Sodium",
      "-",
      "0.24",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Salinomycin Sodium",
      "-",
      "0.5",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Tetrandrine",
      "-",
      "3",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Tetrandrine",
      "-",
      "13.5",
      "-",
      "-",
      "KOR/KCDC03/2020",
      "Calu-3",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.12.090035 "
    ],
    [
      "Cycloheximide",
      "-",
      "0.17",
      "-",
      ">0.5",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "Emetine",
      "-",
      "0.47",
      "-",
      ">1",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "Pladienolide B",
      "-",
      "0.0013",
      "-",
      "0.007",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "2-Deoxy-D-glucose",
      "-",
      "0.41",
      "-",
      "9.09",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "NMS-873",
      "-",
      "0.025",
      "Toxic?",
      "0.025",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "Ribavirin",
      "-",
      "0.07",
      "Toxic?",
      "0.07",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "RT-qPCR",
      "Rotitest Vital (Roth)",
      "https://doi.org/10.1038/s41586-020-2332-7"
    ],
    [
      "Retro-2.1",
      "-",
      "0.4909",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "Chloroquine",
      "-",
      "1.03",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "N-Nonyl  Deoxynojirimycin",
      "NN-DNJ",
      "1.677",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "URMC-099-C",
      "-",
      "0.335",
      "-",
      "13.1",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "Remdesivir",
      "-",
      "1.842",
      "-",
      "50",
      "M\u00fcnchen-1.1/2020/929",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "CellTox\u2122 green",
      "https://doi.org/10.1101/2020.05.17.100404"
    ],
    [
      "Favipiravir",
      "T-705",
      "207.1",
      "-",
      ">500",
      "strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Blue\u00ae reagent",
      "https://doi.org/10.1101/2020.05.15.098731"
    ],
    [
      "Miglustat",
      "Zavesca; N-butyl-1-deoxynojirimycin, NB-DNJ",
      "41\u00b122",
      "-",
      ">1000",
      "strain ICGEB-FVG_5",
      "Vero E6",
      "30 viral PFU/48-well",
      "Plaque assay",
      "alamar blue",
      "https://doi.org/10.1101/2020.05.18.101691"
    ],
    [
      "Oseltamivir Carboxylic Acid",
      "-",
      ">100",
      "Inactive",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.15.20102392"
    ],
    [
      "GZ-161",
      "-",
      "~2",
      "-",
      "-",
      "GISAID accession EPI_ISL_406862",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "XXT single conc.",
      " https://doi.org/10.1101/2020.05.18.103283"
    ],
    [
      "GZ-346",
      "-",
      "~2",
      "-",
      "-",
      "GISAID accession EPI_ISL_406863",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "XXT single conc.",
      " https://doi.org/10.1101/2020.05.18.103283"
    ],
    [
      "Gemcitabine",
      "-",
      "1.24",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "Lycorine",
      "-",
      "0.31",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "Oxysophoridine",
      "-",
      "0.18",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "Chloroquine",
      "-",
      "1.36",
      "Active",
      ">40",
      "WIV04",
      "Vero E6",
      "0.005",
      "RT-qPCR",
      "CCK-8 kit",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "Gemcitabine",
      "-",
      "-",
      "Active",
      "-",
      "WIV04",
      "Huh-7",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "Lycorine",
      "-",
      "-",
      "Active",
      "-",
      "WIV04",
      "Huh-7",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "Oxysophoridine",
      "-",
      "-",
      "Active",
      "-",
      "WIV04",
      "Huh-7",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1080/22221751.2020.1772676 "
    ],
    [
      "ROC-325",
      "-",
      "3.28",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "Clomipramine",
      "-",
      "13.6",
      "-",
      ">30",
      "USA-WA1/2021",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "Hycanthone",
      "-",
      "5.79",
      "-",
      "14",
      "USA-WA1/2022",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "Verteporfin",
      "-",
      "-",
      "Inactive",
      ">30",
      "USA-WA1/2023",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "Chloroquine",
      "-",
      "2.01",
      "-",
      ">30",
      "USA-WA1/2024",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "4.47",
      "-",
      ">30",
      "USA-WA1/2025",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "Mefloquine",
      "-",
      "3.85",
      "-",
      "8.78",
      "USA-WA1/2026",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "Remdesivir",
      "-",
      "7.04",
      "-",
      "-",
      "USA-WA1/2027",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTitre-Glo",
      "CellTitre-Glo",
      "https://doi.org/10.1101/2020.05.16.091520"
    ],
    [
      "CbAE-1",
      "-",
      "0.7344",
      "-",
      "653.1",
      "pseudo SARS-CoV-2",
      "HEK-293T-ACE2",
      "-",
      "Neutralization Assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "CbAE-1",
      "-",
      "2.991",
      "-",
      "653.1",
      "-",
      "Vero",
      "-",
      "Plaque assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "CbAE-2",
      "-",
      "1.041",
      "-",
      ">1000",
      "pseudo SARS-CoV-2",
      "HEK-293T-ACE2",
      "-",
      "Neutralization Assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "CbAE-2",
      "-",
      "2.49",
      "-",
      ">1000",
      "-",
      "Vero",
      "-",
      "Plaque assay",
      "MTT",
      " https://doi.org/10.1101/2020.05.22.109900"
    ],
    [
      "Simeprevir",
      "-",
      "4.082",
      "-",
      "19.33",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      " https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Remdesivir",
      "-",
      "4.269",
      "-",
      ">200",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Bromocriptine Mesylate",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Bictegravir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Entecavir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Zidovudine",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Sofosbuvir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Atovaquone",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Daclatasvir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Saquinavir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Asunaprevir",
      "-",
      ">10",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.05.26.116020"
    ],
    [
      "Chloroquine Diphosphate, Racemic",
      "-",
      "1.801",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "R-Chloroquine Diphosphate",
      "-",
      "1.975",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "S-Chloroquine Diphosphate",
      "-",
      "1.761",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "HydroxyChloroquine Sulfate, Racemic",
      "-",
      "1.752",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "R-HydroxyChloroquine Sulfate",
      "-",
      "2.445",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "S-HydroxyChloroquine Sulfate",
      "-",
      "1.444",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "Azithromycin",
      "-",
      "~10",
      "-",
      "-",
      "Genebank accession no. MT123290.1",
      "Vero E6",
      "0.05",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.26.114033"
    ],
    [
      "Amiodarone",
      "-",
      "0.052",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Bosutinib",
      "-",
      "0.02",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Clofazamine",
      "-",
      "0.084",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Gilteritinib",
      "-",
      "0.224",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Verapamil",
      "-",
      "0.533",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Thioguanine",
      "-",
      "0.216",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Z-FA-FMK",
      "-",
      "0.107",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Metociopramide",
      "-",
      "0.468",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "S1RA",
      "-",
      "0.222",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Entecavir",
      "-",
      "0.042",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Remdesivir",
      "-",
      "0.006",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Niclosamide",
      "-",
      "0.142",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Fedratinib",
      "-",
      "0.024",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Lomitapide",
      "-",
      "0.766",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Lactoferrin",
      "-",
      "0.308",
      "-",
      ">1",
      "USA-WA1/2020",
      "Huh-7",
      "0.2",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.05.27.117184"
    ],
    [
      "Interferon-\u03b21A",
      "IFN-\u03b21a",
      "0.76 IU/ml",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero",
      "0.01",
      "TCID50",
      "-",
      "https://doi.org/10.1016/j.antiviral.2020.104811"
    ],
    [
      "Interferon-\u0251",
      "IFN-\u03b1",
      "1.35 IU/ml\u00a0",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero",
      "0.01",
      "TCID50",
      "-",
      "https://doi.org/10.1016/j.antiviral.2020.104811"
    ],
    [
      "Remdesivir",
      "-",
      "0.826",
      "-",
      ">20",
      "Wuhan-Hu-1 isolate",
      "Vero E6",
      "0.025",
      "Immunofluorescence",
      "MTT",
      "https://doi.org/10.21203/rs.3.rs-30934/v1"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "0.733",
      "-",
      ">20",
      "Wuhan-Hu-1 isolate",
      "Vero E6",
      "0.025",
      "Immunofluorescence",
      "MTT",
      "https://doi.org/10.21203/rs.3.rs-30934/v1"
    ],
    [
      "Famotidine",
      "-",
      ">100",
      "-",
      ">100",
      "Wuhan-Hu-1 isolate",
      "Vero E6",
      "0.025",
      "Immunofluorescence",
      "MTT",
      "https://doi.org/10.21203/rs.3.rs-30934/v1"
    ],
    [
      "Ivermectin",
      "-",
      "2.2 - 2.8",
      "-",
      "-",
      "Australia/VIC01/2020",
      "Vero/hSLAM",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.antiviral.2020.104787"
    ],
    [
      "Remdesivir",
      "-",
      "0.38",
      "-",
      ">100 ",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "Cytopathic effect by MTT",
      "Rotitest Vital",
      "https://doi.org/doi:10.1016/j.ijid.2020.05.085"
    ],
    [
      "Darunavir",
      "-",
      ">100",
      "Inactive",
      ">100 ",
      "Patient Isolate",
      "Caco-2",
      "0.01",
      "Cytopathic effect by MTT",
      "Rotitest Vital",
      "https://doi.org/doi:10.1016/j.ijid.2020.05.085"
    ],
    [
      "Remdesivir",
      "-",
      "23.15, 26.9",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Lopinavir",
      "-",
      "26.63, 26.10",
      "-",
      "49.75",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Homorringtonine",
      "-",
      "2.55, 2.14",
      "-",
      "59.75",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Emetine Hydrochloride",
      "-",
      "0.46, 0.50",
      "-",
      "56.46",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Ribavirin",
      "-",
      ">500",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Galidesivir",
      "-",
      ">100",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Favipiravir",
      "-",
      ">100",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Oseltamivir Carboxylate",
      "-",
      ">100",
      "-",
      ">100",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Baloxivir",
      "-",
      ">100",
      "-",
      "85.9",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "R-1479",
      "-",
      ">100",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Tenofovor",
      "-",
      ">100",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Fludarabine",
      "-",
      ">100",
      "-",
      "-",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Ritonavir",
      "-",
      ">100",
      "-",
      "48.91",
      "Hong Kong/VM20001061/2020",
      "Vero E6",
      "0.02",
      "TCID50/RT-qPCR",
      "CellTitre-Glo",
      "https://doi.org/10.1016/j.antiviral.2020.104786"
    ],
    [
      "Cetilistat",
      "-",
      "1.13",
      "-",
      ">100.00",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Diiodohydroxyquinoline",
      "-",
      "1.38",
      "-",
      ">100.00",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Abiraterone Acetate",
      "-",
      "1.94",
      "-",
      "92.35",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Bexarotene",
      "-",
      "2.01",
      "-",
      "38.21",
      "HKU-001a",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "CellTiterGlo\u00ae",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Cetilistat",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Diiodohydroxyquinoline",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Abiraterone Acetate",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Bexarotene",
      "-",
      "-",
      "Active",
      "-",
      "HKU-001a",
      "Vero E6/Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1016/j.phrs.2020.104960"
    ],
    [
      "Clomiphene Citrate",
      "-",
      "9.73",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "Vortioxetine",
      "-",
      "8.03",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "Vortioxetine Hydrobromide",
      "-",
      "28.11",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "Asenapine",
      "-",
      "16.7",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "Chloroquine Diphosphate",
      "-",
      "5.33",
      "-",
      "-",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "100x TCID50",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.06.05.135996"
    ],
    [
      "GC376",
      "-",
      "0.18",
      "-",
      ">200",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "cell counting kit-8 (GK10001, GLPBIO)",
      "https://doi.org/10.1101/2020.06.07.138677"
    ],
    [
      " 25-Hydroxy-cholesterol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "HEK293-hACE2",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.08.141077"
    ],
    [
      "7\u0251,25-Dihydroxy-cholesterol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "HEK293-hACE2",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.08.141077"
    ],
    [
      "Fluoxtine",
      "-",
      "2.5ng/ml",
      "-",
      "-",
      "Patient Isolate",
      "Vero",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.14.150490"
    ],
    [
      "Lasalocid",
      "-",
      "0.36",
      "-",
      "24",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Salinomycin",
      "-",
      "0.097",
      "-",
      "26",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Monensin",
      "-",
      "0.097",
      "-",
      "26",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Nanchangmycin",
      "-",
      "0.066",
      "-",
      "7.2",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Ionomycin",
      "-",
      "3",
      "-",
      "15",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Calcimysin",
      "-",
      "0.26",
      "-",
      "4.7",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "X-206",
      "-",
      "0.014",
      "-",
      "8.2",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Indanomycin",
      "-",
      "0.63",
      "-",
      "30",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Nigericin",
      "-",
      "0.089",
      "-",
      "7.4",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Maduramycin",
      "-",
      "0.064",
      "-",
      "20",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Naracin",
      "-",
      "0.071",
      "-",
      "7.4",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "HL201",
      "-",
      "2.4",
      "-",
      "11",
      "strain #291.3 FR-4286",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Microscopy",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.06.14.149153"
    ],
    [
      "Boceprevir",
      "-",
      "0.58",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "Boceprevir",
      "-",
      "1.95",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "Calpain inhibitor II",
      "-",
      "2.07",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "Calpain inhibitor II",
      "-",
      "3.7",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "Calpain inhibitor XII",
      "-",
      "0.49",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "Calpain inhibitor XII",
      "-",
      "0.78",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "GC-376",
      "-",
      "3.37",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Cytopathic effect by Neutral Red Uptake",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "GC-376",
      "-",
      "3.14",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero 76",
      "60x CCID50",
      "Viral Yield Reduction assay",
      "neutral red uptake",
      "https://doi.org/10.1038/s41422-020-0356-z"
    ],
    [
      "Amprenavir",
      "-",
      "31.32",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Darunavir",
      "-",
      "46.41",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Indinavir",
      "-",
      "59.14",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Tipranavir",
      "-",
      "13.34",
      "-",
      "76.8",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Ritonavir",
      "-",
      "8.63",
      "-",
      "74.11",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Saquinavir",
      "-",
      "8.83",
      "-",
      "44.43",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Atazanavir",
      "-",
      "9.36",
      "-",
      ">81",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Lopinavir",
      "-",
      "5.73",
      "-",
      "74.44",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "Nelfinavir",
      "-",
      "1.13",
      "-",
      "24.32",
      "-",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2020.04.06.026476"
    ],
    [
      "CPI1155",
      "-",
      "8.4",
      "-",
      ">40",
      "USA-WA1/2020",
      "HeLa166 ACE2",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.16.154765"
    ],
    [
      "CPI1062",
      "-",
      "0.54",
      "-",
      ">40",
      "USA-WA1/2020",
      "HeLa166 ACE2",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.16.154765"
    ],
    [
      "ATN-161",
      "-",
      "3.16",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.15.153387"
    ],
    [
      "Daclatasvir",
      "-",
      "0.8",
      "-",
      "31",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Daclatasvir",
      "-",
      "0.6",
      "-",
      "28",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Daclatasvir",
      "-",
      "1.1",
      "-",
      "38",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Sofosbuvir",
      "-",
      ">1",
      "-",
      "360",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Sofosbuvir",
      "-",
      "6.2",
      "-",
      "381",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Sofosbuvir",
      "-",
      "9.5",
      "-",
      "512",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Ribavirin",
      "-",
      "6.5",
      "-",
      "142",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Ribavirin",
      "-",
      "8.6",
      "-",
      "160",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Chloroquine",
      "-",
      "1.3",
      "-",
      "268",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Lopinavir/Ritonavir",
      "-",
      "3.3",
      "-",
      "291",
      "Patient Isolate",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Lopinavir/Ritonavir",
      "-",
      "2.9",
      "-",
      "328",
      "Patient Isolate",
      "Huh-7",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Lopinavir/Ritonavir",
      "-",
      "4.2",
      "-",
      "256",
      "Patient Isolate",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.06.15.153411"
    ],
    [
      "Aloxistatin",
      "-",
      "0.3",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Aloxistatin",
      "-",
      "26",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Aloxistatin",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "AM-1241",
      "-",
      "0.008",
      "-",
      "24",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "AM-1241",
      "-",
      "16.7",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "AM-1241",
      "-",
      "20",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Amodiaquine",
      "-",
      "0.58",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Amodiaquine",
      "-",
      "1.617",
      "-",
      "35.79",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Amodiaquine",
      "-",
      "22.39",
      "-",
      "100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Apilimod",
      "-",
      "<0.003 ",
      "-",
      "25.168",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Apilimod",
      "-",
      "0.007",
      "-",
      "12.08",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Apilimod",
      "-",
      "4.543",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "AZD8055",
      "-",
      "1.1",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "AZD8055",
      "-",
      "1.1",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "AZD8055",
      "-",
      "0.003",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Azilsartan",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Azilsartan",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Azilsartan",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Bemcentinib",
      "-",
      "2.1",
      "-",
      "16.4",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Bemcentinib",
      "-",
      "0.1",
      "-",
      "4.7",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Bemcentinib",
      "-",
      "0.47",
      "-",
      "1.6",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "BIX01294",
      "-",
      "0.09",
      "-",
      "12.3",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "BIX01294",
      "-",
      "0.48",
      "-",
      "14.8",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "BIX01294",
      "-",
      "4.9",
      "-",
      "11.5",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Camostat",
      "-",
      ">100",
      "-",
      ">100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Camostat",
      "-",
      ">100",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Camostat",
      "-",
      "0.35",
      "-",
      ">100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cepharanthine",
      "-",
      "0.01",
      "-",
      "21",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cepharanthine",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cepharanthine",
      "-",
      "20.6",
      "-",
      "42.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Chloroquine",
      "-",
      "0.85",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Chloroquine",
      "-",
      "5.03",
      "-",
      "99.76",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Chloroquine",
      "-",
      "25.53",
      "-",
      "100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin A",
      "-",
      "1",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin A",
      "-",
      "2.2",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin A",
      "-",
      "19.55",
      "-",
      "47.39",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin B",
      "-",
      "2.6",
      "-",
      "32.6",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin B",
      "-",
      "3.1",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin B",
      "-",
      "25.22",
      "-",
      "20.45",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin C",
      "-",
      "5.4",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin C",
      "-",
      "8.4",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin C",
      "-",
      "38.45",
      "-",
      "44.43",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin H",
      "-",
      "8",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin H",
      "-",
      "11.9",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporin H",
      "-",
      "35.08",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporine",
      "-",
      "0.24",
      "-",
      ">50 ",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporine",
      "-",
      "0.9",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporine",
      "-",
      "1.5",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporine",
      "-",
      "0.87",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Cyclosporine",
      "-",
      "24",
      "-",
      "46",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Dacomitinib",
      "-",
      "0.79",
      "-",
      "11.9",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Dacomitinib",
      "-",
      "1.4",
      "-",
      "4.2",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Dacomitinib",
      "-",
      "0.04",
      "-",
      "9.036",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Disulfiram",
      "-",
      "43",
      "-",
      "16.7",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Disulfiram",
      "-",
      "5.9",
      "-",
      "2.2",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Disulfiram",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Dp44mT",
      "-",
      "0.09",
      "-",
      ">50 ",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Dp44mT",
      "-",
      "1.6",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Dp44mT",
      "-",
      "0.18",
      "-",
      "0.011",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Ebastine",
      "-",
      "1.2",
      "-",
      "13.4",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Ebastine",
      "-",
      "5.45",
      "-",
      "19",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Ebastine",
      "-",
      "1.9",
      "-",
      "13.6",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Ferroquine",
      "-",
      "1.8",
      "-",
      ">10",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Ferroquine",
      "-",
      ">10 ",
      "-",
      ">10",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Ferroquine",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "FK506",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "FK506",
      "-",
      "39.5",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "FK506",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "FRAX486",
      "-",
      "0.006",
      "-",
      "11.5",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "FRAX486",
      "-",
      "1.1",
      "-",
      "0.23",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "FRAX486",
      "-",
      "10.8",
      "-",
      "10.8",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Gatifloxacin",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Gatifloxacin",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Gatifloxacin",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "1.32",
      "-",
      "100",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "0.14",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "39.16",
      "-",
      ">100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Isocyclosporin A",
      "-",
      "0.5",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Isocyclosporin A",
      "-",
      "0.2",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Isocyclosporin A",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Leupeptin Hemisulfate",
      "-",
      "0.03",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Leupeptin Hemisulfate",
      "-",
      "44.9",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Leupeptin Hemisulfate",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "MG-101",
      "-",
      "0.005",
      "-",
      "34.4",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "MG-101",
      "-",
      ">50 ",
      "-",
      "12.9",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "MG-101",
      "-",
      "6.703",
      "-",
      "11.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "MG132",
      "-",
      "0.002",
      "-",
      "2.9",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "MG132",
      "-",
      "0.011",
      "-",
      "0.38",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "MG132",
      "-",
      "0.477",
      "-",
      "0.405",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Nanchangmycin",
      "-",
      "0.01",
      "-",
      "2.97",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Nanchangmycin",
      "-",
      "0.01",
      "-",
      "7.228",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Nanchangmycin",
      "-",
      "0.01",
      "-",
      ">6.66",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Naquotinib",
      "-",
      "0.055",
      "-",
      "79.3",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Naquotinib",
      "-",
      "0.311",
      "-",
      "0.434",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Naquotinib",
      "-",
      "4.85",
      "-",
      "1.228",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "N-Desethylamodiaquine",
      "-",
      "0.4",
      "-",
      ">40",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "N-Desethylamodiaquine",
      "-",
      "2.948",
      "-",
      "40",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "N-Desethylamodiaquine",
      "-",
      "40",
      "-",
      "12.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "NFAT inhibitor",
      "-",
      ">20 ",
      "-",
      ">20",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "NFAT inhibitor",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "NFAT inhibitor",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "NIM811",
      "-",
      "0.09142",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Oxfendazole",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Oxfendazole",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Oxfendazole",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PD0166285",
      "-",
      "0.02",
      "-",
      "78",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PD0166285",
      "-",
      "0.72",
      "-",
      "0.008",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PD0166285",
      "-",
      "6.4",
      "-",
      "0.034",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PF-04691502",
      "-",
      "0.1",
      "-",
      "39",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PF-04691502",
      "-",
      "1.5",
      "-",
      "1.2",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PF-04691502",
      "-",
      "5.5",
      "-",
      "8.3",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Piperaquine",
      "-",
      "2.1",
      "-",
      ">100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Piperaquine",
      "-",
      ">100 ",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Piperaquine",
      "-",
      ">100 ",
      "-",
      ">100",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Primidone",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Primidone",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Primidone",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PSC-833",
      "-",
      "4.8",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PSC-833",
      "-",
      "4.5",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "PSC-833",
      "-",
      "40.85",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Pyronaridine",
      "-",
      "0.18",
      "-",
      "1.798",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Pyronaridine",
      "-",
      "3.204",
      "-",
      "1.696",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Pyronaridine",
      "-",
      "1.396",
      "-",
      "5.048",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Remdesivir",
      "-",
      "0.46",
      "-",
      ">40",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Remdesivir",
      "-",
      "0.002",
      "-",
      "100",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Remdesivir",
      "-",
      "0.005",
      "-",
      ">40",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Salinomycin",
      "-",
      "0.17",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Salinomycin",
      "-",
      "0.003",
      "-",
      "30.9",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Salinomycin",
      "-",
      "0.005",
      "-",
      "41.9",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Strontium Ranelate",
      "-",
      "2",
      "-",
      "2",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Strontium Ranelate",
      "-",
      "-",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Strontium Ranelate",
      "-",
      ">2",
      "-",
      ">2",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Sulconazole Nitrate",
      "-",
      "50",
      "-",
      "50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Sulconazole Nitrate",
      "-",
      ">50 ",
      "-",
      "16",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Sulconazole Nitrate",
      "-",
      "24.9",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Suplatast Tosilate",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Suplatast Tosilate",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Suplatast Tosilate",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Tetrandrine",
      "-",
      "0.34",
      "-",
      ">2",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Tetrandrine",
      "-",
      "-",
      "-",
      "nd",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Tetrandrine",
      "-",
      ">2",
      "-",
      ">2",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "TMN355",
      "-",
      ">50 ",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "TMN355",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "UNC0631",
      "-",
      "0.15",
      "-",
      "28.6",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "UNC0631",
      "-",
      "50",
      "-",
      "50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "UNC0631",
      "-",
      "50",
      "-",
      "50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "WYE-125132",
      "-",
      "0.075",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "WYE-125132",
      "-",
      "0.63",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "WYE-125132",
      "-",
      "0.14",
      "-",
      "39.6",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Y-320",
      "-",
      "0.17",
      "-",
      "26.4",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Y-320",
      "-",
      "0.12",
      "-",
      ">40",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Y-320",
      "-",
      "0.09",
      "-",
      "0.75",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Z-FA-FMK",
      "-",
      "0.014",
      "-",
      ">50",
      "USA-WA1/2020",
      "Huh7.5",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Z-FA-FMK",
      "-",
      "0.2",
      "-",
      ">50",
      "USA-WA1/2020",
      "Vero CCL81",
      "1",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Z-FA-FMK",
      "-",
      ">50",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.5",
      "Viral Infectivity Assay-Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.06.19.161042"
    ],
    [
      "Citicoline",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Pravastatin Sodium",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Tenofovir Alafenamide",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Imatinib Mesylate",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Calcitriol",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Dexlansoprazole",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Prochlorperazine Dimaleate",
      "-",
      "-",
      "Active",
      "-",
      "Singapore/10/2020",
      "Vero E6, Huh-7",
      "1",
      "Cytopathic effect by AlamarBlue",
      "AlamarBlue",
      "https://doi.org/10.1101/2020.06.21.162396"
    ],
    [
      "Pixatimod",
      "PG545",
      " 2.4 ug/ml",
      "-",
      ">236 ug/ml",
      "Victoria/01/2020",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS",
      "https://doi.org/10.1101/2020.06.24.169334"
    ],
    [
      "Pixatimod",
      "PG545",
      " 2.7 ug/ml",
      "-",
      ">236 ug/ml",
      "DE",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS",
      "https://doi.org/10.1101/2020.06.24.169334"
    ],
    [
      "Pixatimod",
      "PG545",
      " 8.0 ug/ml",
      "-",
      ">236 ug/ml",
      "QLD02",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS",
      "https://doi.org/10.1101/2020.06.24.169334"
    ],
    [
      "Tipiracil",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "A549-hACE2",
      "1",
      "RT-qPCR",
      "CellTracker\u2122 Red",
      "https://doi.org/10.1101/2020.06.26.173872"
    ],
    [
      "Berzosertib",
      "-",
      "0.00483",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero-E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "Berzosertib",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "human iPSC cardiomyocytes",
      "-",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "AZD2014",
      "-",
      "0.01593",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "Nilotinib",
      "-",
      "0.08",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "NVP-BHG712",
      "-",
      "0.106",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "YM201636",
      "-",
      "0.06",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "URMC-099",
      "-",
      "0.085",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "AZD8055",
      "-",
      "0.025",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "Torin 2",
      "-",
      "0.00688",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.06.24.150326"
    ],
    [
      "Nitazoxanide+Remdesivir",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Nitazoxanide+Amodiaquine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Nitazoxanide+Umifenovir",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Umifenovir+Mefloquine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Umifenovir+Amodiaquine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Umifenovir+Emetine",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Umifenovir+Lopinavir",
      "-",
      "-",
      "Active, Synergistic\n",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "Remdesivir+HydroxyChloroquine",
      "-",
      "-",
      "Antagonistic",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      "https://doi.org/10.1101/2020.06.29.178889"
    ],
    [
      "\u03b11-Antitrypsin",
      "-",
      "0.58 mg/ml",
      "-",
      "-",
      "France/IDF0372/2020",
      "Vero E6",
      "0.001",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "\u03b11-Antitrypsin",
      "-",
      "0.81 mg/ml",
      "-",
      "-",
      "Netherlands/01/NL/2020",
      "Vero E6",
      "0.001",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "\u03b11-Antitrypsin",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "human airway epithelial cells (HAECs)",
      "-",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0372/2020",
      "human airway epithelial cells (HAECs)",
      "-",
      "Immunohistochemistry",
      "-",
      "https://doi.org/10.1101/2020.07.02.183764"
    ],
    [
      "DHODHi S312",
      "-",
      "1.55",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "DHODHi S416",
      "-",
      "0.017",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "Teriflunomide",
      "-",
      "26.06",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "Teriflunomide",
      "-",
      "6.001",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.03",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "Leflunomide",
      "-",
      "63.56",
      "-",
      "-",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.03.11.983056"
    ],
    [
      "Tafenoquine",
      "-",
      "15.7",
      "-",
      "37.2",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by MTT",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "Remdesivir",
      "-",
      "0.77",
      "-",
      "NT",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by MTT",
      "-",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "hydroxyChloroquine",
      "-",
      ">100",
      "-",
      "55.5",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by MTT",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "Tafenoquine",
      "-",
      "2.6",
      "-",
      "37.2",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Yield Reduction",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "hydroxyChloroquine",
      "-",
      "10.4",
      "-",
      "55.5",
      "Australia/VIC01/2020",
      "Vero E6",
      "0.05",
      "Yield Reduction",
      "MTT",
      "https://doi.org/10.1101/2020.07.12.199059"
    ],
    [
      "Ethaverine",
      "-",
      ">20",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "NKH477",
      "-",
      ">20",
      "-",
      "7.08",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Trimipramine",
      "-",
      "10",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Osimertinib",
      "-",
      ">20",
      "-",
      "11.22",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Ingenol",
      "-",
      ">20",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Cepharanthine",
      "-",
      "2",
      "-",
      ">20",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Abemaciclib",
      "-",
      "7.94",
      "-",
      "11.22",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Copanlisib",
      "-",
      ">20",
      "-",
      "0.14",
      "USA-WA1/2020",
      "Vero E6",
      "0.002",
      "Cytopathic effect by CellTiter-Glo",
      "-",
      " https://doi.org/10.1101/2020.07.10.197988"
    ],
    [
      "Chloroquine ",
      "-",
      "4.7",
      "-",
      " >50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Nitazoxanide",
      "-",
      "1",
      "-",
      "3.3",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Ivermectin",
      "-",
      "1.7",
      "-",
      "2.2",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Brequinar",
      "-",
      "0.3",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "U-73343",
      "-",
      "2.7",
      "-",
      "9.6",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "6-Azauridine",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "5-Fluorouracil",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Benztropine",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Bafilomycin A1",
      "-",
      ">50",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Abiraterone acetate",
      "-",
      "7.1",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Neomycin",
      "-",
      "12.9",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "Hedera helix",
      "-",
      "51 \u00b5g/mL",
      "-",
      ">50",
      "SP02/human/2020/BRA, GenBank Accession No. MT126808.1",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "Microscopy",
      "https://doi.org/10.1101/2020.07.09.196337"
    ],
    [
      "oleandrin",
      "-",
      "7.07ng/ml",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero CCL81",
      "0.01",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.15.203489"
    ],
    [
      "Famotidine",
      "-",
      ">200",
      "Inactive",
      ">200",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "Famotidine",
      "-",
      ">200",
      "Inactive",
      ">200",
      "USA-WA1/2020",
      "A549",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "Remdesivir",
      "-",
      "3.3",
      "-",
      "17.57",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "Remdesivir",
      "-",
      "0.43",
      "-",
      "14.62",
      "USA-WA1/2020",
      "A549",
      "0.1",
      "RT-qPCR/Immunofluorescence",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.07.15.203059"
    ],
    [
      "Azithromycine",
      "-",
      "2.12",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Omeprazole ",
      "-",
      "17.06",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Oxprenolol hydrochloride",
      "-",
      "20.22",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Hydroxy-Chloroquine ",
      "-",
      "4.17",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Clemizole hydrochloride ",
      "-",
      "23.94",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Alprostadil ",
      "-",
      "5.39",
      "-",
      " >40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Dolutegravir  ",
      "-",
      "22.04",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Sulfadoxine",
      "-",
      "35.37",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Opipramol dihydrochloride",
      "-",
      "5.05",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Quinidine hydrochloride monohydrate",
      "-",
      "5.11",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Arbidol ",
      "-",
      "10.7",
      "-",
      ">40",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "Remdesivir",
      "-",
      "1.65\u00b10.79",
      "-",
      "n.d.",
      "BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.04.03.023846"
    ],
    [
      "GRL0617",
      "-",
      "~100",
      "-",
      ">100",
      "Shenzhen/SZTH-003/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.07.17.208959"
    ],
    [
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Vero E6",
      "0.1",
      "RT-qPCR/TCID50/Plaque assay",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Calu-3",
      "0.5",
      "RT-qPCR/TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "NuLi",
      "0.5",
      "TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "4-Octyl-itaconate",
      "4-OI",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Primary Human Airway Epithelial",
      "0.1",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "dimethyl fumarate",
      "DMF",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Vero E6",
      "0.1",
      "RT-qPCR/TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "dimethyl fumarate",
      "DMF",
      "-",
      "Active",
      "-",
      "strain #291.3 157 FR-4286 isolated from a patient in Germany",
      "Calu-3",
      "0.5",
      "RT-qPCR/TCID50",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.16.206458"
    ],
    [
      "Amlodipine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "Nifedipine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "Felodipine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "Verapamil",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "Diltiazem",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "Diethylenetriaminepentaacetic Acid",
      "DTPA, Pentetic Acid",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6, Calu-3",
      "0.1",
      "TCID50",
      "MTT",
      "https://doi.org/10.1101/2020.07.21.214577"
    ],
    [
      "VPS34-IN1",
      "-",
      "0.29",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "VPS34-IN1",
      "-",
      "0.55",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "PIKIII",
      "-",
      "0.202",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "PIKIII",
      "-",
      "0.12",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "Orlistat",
      "-",
      "422.3",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "Orlistat",
      "-",
      "21.25",
      "-",
      ">1000",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "Triacsin C",
      "-",
      "19.5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "Triacsin C",
      "-",
      "0.04",
      "-",
      ">50",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "CellTox Green",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "TC863",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "PF06424439",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "BYL719",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "Remdesivir",
      "-",
      "1.54",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect by Electrical Impedance",
      "-",
      "https://doi.org/10.1101/2020.07.18.210211"
    ],
    [
      "VIP (Vasoactive intestinal peptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Monocytes",
      "0.01",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "VIP (Vasoactive intestinal peptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Calu-3",
      "0.1",
      "Cytopathic effect by Lactate Dehydrogenase",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "PACAP (Pituitary adenylate cyclase-activating polypeptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Monocytes",
      "0.01",
      "RT-qPCR",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "PACAP (Pituitary adenylate cyclase-activating polypeptide)",
      "-",
      "-",
      "Active",
      "-",
      "GenBank accession no. MT710714",
      "Calu-3",
      "0.1",
      "Cytopathic effect by Lactate Dehydrogenase",
      "Lactate Dehydrogenase",
      "https://doi.org/10.1101/2020.07.25.220806"
    ],
    [
      "GC376",
      "-",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI2",
      "-",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI5",
      "-",
      "<5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI6",
      "-",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI10",
      "11a",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI5",
      "-",
      "<5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI7",
      "-",
      "<5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI8",
      "-",
      "<2.5",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI5",
      "-",
      "<0.310",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI7",
      "-",
      ">10",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI8",
      "-",
      "<0.310",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI10",
      "11a",
      "<10",
      "-",
      "-",
      "USA-WA1/2020",
      "A549",
      "-",
      "Cytopathic effect by Microscopy",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "Pyronaridine",
      "-",
      "1.084/ 2.235",
      "-",
      "37.09",
      "South Korea/KCDC03/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "Artesunate",
      "-",
      "53.06/ 23.51",
      "-",
      ">100",
      "South Korea/KCDC03/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "1.069/ 11.19",
      "-",
      "-",
      "South Korea/KCDC03/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "102.9/ 107.8",
      "-",
      "-",
      "South Korea/KCDC03/2020",
      "Calu-3",
      "0.1",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "Pyronaridine",
      "-",
      "6.413/8.577",
      "-",
      "43.08",
      "South Korea/KCDC03/2020",
      "Calu-3",
      "0.1",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "Artesunate",
      "-",
      "1.76/0.453",
      "-",
      ">100",
      "South Korea/KCDC03/2020",
      "Calu-3",
      "0.1",
      "RT-qPCR",
      "WST-1",
      "https://doi.org/10.1101/2020.07.28.225102"
    ],
    [
      "MPI1",
      "-",
      ">10",
      "Inactive at 10uM",
      "-",
      "-",
      "Vero E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI3",
      "-",
      ">10",
      "Inactive at 10uM",
      "-",
      "-",
      "Vero E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "MPI4",
      "-",
      ">10",
      "Inactive at 10uM",
      "-",
      "-",
      "Vero E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.07.28.223784"
    ],
    [
      "PTC299",
      "-",
      "0.00196",
      "-",
      ">10",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Quantitative Image Analysis",
      "quantitative image analysis",
      "https://doi.org/10.1101/2020.08.05.238394"
    ],
    [
      "Camostat",
      "Camostat mesylate",
      "~0.1",
      "-",
      "-",
      "Germany/FI1103201/2020",
      "Calu-3",
      "0.01/0.001",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.05.237651"
    ],
    [
      "FOY-251",
      "-",
      "~0.2",
      "-",
      "-",
      "Germany/FI1103201/2020",
      "Calu-3",
      "0.01/0.001",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.05.237651"
    ],
    [
      "NaCl",
      "Hypertonic saline solution",
      "-",
      "Active",
      "-",
      "SP02/human/2020/BRA",
      "Vero CCL-81",
      "-",
      "RT-PCR",
      "AlamarBlue,LDH",
      "https://doi.org/10.1101/2020.08.04.235549"
    ],
    [
      "Compound 4",
      "-",
      "3.023",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "XTT Cell Proliferation Assay Kit",
      "https://doi.org/10.1101/2020.08.03.235291"
    ],
    [
      "GC376",
      "-",
      "4.481",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "XTT Cell Proliferation Assay Kit",
      "https://doi.org/10.1101/2020.08.03.235291"
    ],
    [
      "MAC-5576",
      "-",
      "-",
      "Inactive",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "XTT Cell Proliferation Assay Kit",
      "https://doi.org/10.1101/2020.08.03.235291"
    ],
    [
      "Polyman26",
      "-",
      "-",
      "Active",
      "-",
      "-",
      "monocyte-derived dendritic cells=>Vero E6",
      "-",
      "Trans-infection",
      "-",
      "https://doi.org/10.1101/2020.08.09.242917"
    ],
    [
      "Tafenoquine",
      "Krintafel, Arakoda, Etaquine, WR 238605, SB-252263",
      "-",
      "Active",
      "-",
      "NTU02 (GenBank:MT066176.1)",
      "Vero E6",
      "0.001",
      "RT-qPCR, Bytopathic Effect",
      "-",
      "https://doi.org/10.1101/2020.08.14.250258"
    ],
    [
      "Methylene Blue",
      "-",
      "-",
      "Active",
      "84.72",
      "Switzerland/GE9586/2020",
      "Vero E6",
      "5*106  pfu",
      "Plaque assay",
      "MTS reagent (Promega)",
      "https://doi.org/10.1101/2020.08.14.251090"
    ],
    [
      "Clioquinol",
      "5- 31 chloro-7-iodo-8-quinolinol",
      "12.62",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "7-bromo-5- 111 chloro-8-hydroxyquinoline",
      "CLBQ14",
      "14.69",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "5, 7-Dichloro-8-hydroxyquinoline",
      "CLCQ",
      "16.3",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "Aloxistatin",
      "E64d",
      "16.72",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "Chloroquine",
      "-",
      "1.1",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "5.04",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "Remdesivir",
      "-",
      "4.42",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "Calpain Inhibitor IV",
      "-",
      "0.41",
      "-",
      ">7.17",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.08.14.250480"
    ],
    [
      "Maraviroc",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Fingolimod",
      "FTY720",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Nitazoxanide",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Atorvastatin",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Bevacizumab ",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Eculizumab",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "CD126/IL6R antibody",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Pirfenidone   ",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Bromhexine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Dipyridamole",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Ciclesonid",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Indomethacin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Darunavir     ",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Danoprevir",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Arbidol",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Valganciclovir",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Rimantadine",
      "-",
      "-",
      "not active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Letermovir",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      " Baloxavir",
      "-",
      "-",
      "Weakly Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Azithromycin   ",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Tiecoplanin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "Plaque assay",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.12.246389"
    ],
    [
      "Chloroquine",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "Azithromycin",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "Ciprofloxacin",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "Ambroxol",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "Bromhexine",
      "-",
      "-",
      "Inactive",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect, qPCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.11.245100"
    ],
    [
      "AT-511",
      "Free base form of AT-527",
      "1.8",
      "-",
      ">100",
      "USA-WA1/2020",
      "Human airway epithelial",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.11.242834"
    ],
    [
      "Proguanil",
      "-",
      "-",
      "Active",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6, Calu-3",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "Sulfasalazine",
      "-",
      "-",
      "Active",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6, Calu-3",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "Flucytosine",
      "-",
      "-",
      "Active",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "Alogliptin",
      "-",
      "-",
      "Inactive",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "Ademetionine",
      "-",
      "-",
      "Inactive",
      "not toxic",
      "M\u00fcnchen-1.2/2020/984",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2020.08.24.265496"
    ],
    [
      "Mometasone furoate",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Ciclesonide",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "0.01",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Ciclesonide",
      "-",
      "<5.1 (EC90)",
      "-",
      "not toxic",
      "WK-521",
      "Vero E6/TMPRSS2",
      "0.001",
      "Plaque assay",
      "WST reagent",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Ciclesonide",
      "-",
      "<6.0 (EC90)",
      "-",
      "not toxic",
      "WK-521",
      "Calu-3",
      "0.001",
      "Plaque assay",
      "WST reagent",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Ciclesonide",
      "-",
      "<0.55 (EC90)",
      "-",
      "-",
      "WK-521",
      "HBTE/ALI cells",
      "0.001",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Nelfinavir",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Lopinavir",
      "-",
      "-",
      "Active",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Fluticasone",
      "-",
      "-",
      "Inactive",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Dexamethasone",
      "-",
      "-",
      "Inactive",
      "-",
      "WK-521",
      "Vero E6/TMPRSS2",
      "1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.08.22.258459"
    ],
    [
      "Lambda-carrageenan",
      "\u03bb-CGN",
      "0.9 \u00b1 1.1 ug/ml",
      "-",
      ">300.0 \u03bcg/ml",
      "Korea/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.08.23.255364"
    ],
    [
      "Remdesivir",
      "-",
      "23.5 \u00b1 1.2",
      "-",
      ">300.0",
      "Korea/KCDC03/2020",
      "Vero",
      "0.1",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.08.23.255364"
    ],
    [
      "Remdesivir  ",
      "-",
      "4.6 \u00b1 2.1",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "Remdesivir nucleoside",
      "-",
      " 1.7 \u00b1 0.13",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "Remdesivir nucleoside, hexadecyloxypropyl-P",
      "HDP-P-RVn",
      "0.96 \u00b1 0.17",
      "-",
      "51",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "Remdesivir nucleoside, octadecyloxyethyl-P-",
      "ODE-P-RVn",
      "0.47 \u00b1 0.18",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "Remdesivir nucleoside, 1-O-octadecyl-2-\nO-benzyl-glycero-3-P-",
      "ODBG-P-RVn",
      "0.19 \u00b1 0.023",
      "-",
      "46",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.26.269159"
    ],
    [
      "Remdesivir",
      "-",
      "0.442",
      "-",
      "-",
      "USA-WA1/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "PF-00835231",
      "-",
      "0.221",
      "-",
      "> 10",
      "USA-WA1/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "Remdesivir",
      "-",
      "0.283",
      "-",
      "-",
      "USA/NYU-VC-003/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "PF-00835231",
      "-",
      "0.184",
      "-",
      "> 10",
      "USA/NYU-VC-003/2020",
      "A549+ACE2",
      "-",
      "High-content microscopy",
      "Cell Titer Glo",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "polarized human airway epithelial cultures (HAEC)",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "PF-00835231",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "polarized human airway epithelial cultures (HAEC)",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.08.28.272880"
    ],
    [
      "Prunella vulgaris extract",
      "-",
      "-",
      "Active",
      "-",
      "Canada/ON-VIDO-01/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.28.270306"
    ],
    [
      "Suramin",
      "-",
      "-",
      "Active",
      "-",
      "Canada/ON-VIDO-01/2020",
      "Vero E6",
      "0.01",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.28.270306"
    ],
    [
      "Silicon nitride",
      "Si3N4",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero",
      "-",
      "Plaque assay",
      "CellTiter Glo",
      "https://doi.org/10.1101/2020.08.29.271015"
    ],
    [
      "GRL-0496",
      "-",
      "9.12",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.2",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.08.29.272864"
    ],
    [
      "PF-00835231",
      "-",
      "39.7",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-00835231",
      "-",
      "88.9",
      "-",
      ">100",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-00835231",
      "-",
      "0.23",
      "In the presence of a P-gp efflux inhibitor",
      ">100",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-00835231",
      "-",
      "0.76",
      "In the presence of a P-gp efflux inhibitor",
      ">50",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-07304814",
      "-",
      "87",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-07304814",
      "-",
      "3.8",
      "-",
      ">100",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-07304814",
      "-",
      ">50",
      "In the presence of a P-gp efflux inhibitor",
      ">50",
      "USA-WA1/2020",
      "Vero E6-enACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "PF-07304814",
      "-",
      "0.83",
      "In the presence of a P-gp efflux inhibitor",
      ">50",
      "GHB-03021/2020 strain (GHB-03021 - EPI_ISL_407976)",
      "Vero E6-EGFP",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.09.12.293498"
    ],
    [
      "Ambroxol Hydrochloride",
      "-",
      ">50",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "Bromhexine Hydrochloride",
      "-",
      "21.72",
      "-",
      ">30",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "Calpain Inhibitor IV",
      "-",
      "0.29",
      "-",
      ">7.17",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "Chloroquine",
      "-",
      "3.56",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "5.16",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "Remdesivir",
      "-",
      "8.54",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "Aloxistatin",
      "E64d",
      "21.78",
      "-",
      ">30.00",
      "USA-WA1/2020",
      "Vero E6",
      "~ 0.002",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.13.295691"
    ],
    [
      "Azelastine-HCl",
      "-",
      "6",
      "-",
      ">25",
      "Hungary/SRC_isolate_2/2020 (Accession ID: EPI_ISL_483637)",
      "Vero E6",
      "0\u00b701",
      "Cytopathic effect",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2020.09.15.296228"
    ],
    [
      "Azelastine-HCl",
      "-",
      "-",
      "Active",
      "-",
      "Hungary/SRC_isolate_2/2020 (Accession ID: EPI_ISL_483637)",
      "reconstituted human nasal tissue",
      "-",
      "Droplet digitalPCR analysis",
      "-",
      "https://doi.org/10.1101/2020.09.15.296228"
    ],
    [
      "ML1000",
      "-",
      "0.1",
      "-",
      ">100",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "ML1100",
      "-",
      "0.2",
      "-",
      ">100",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "Boceprevir",
      "-",
      "0.2",
      "-",
      "-",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "GC-376",
      "-",
      "0.0001",
      "-",
      "-",
      "USA-WA1/2020",
      "Caco-2",
      "-",
      "Virus yield reduction assays",
      "-",
      "\u00a0https://doi.org/10.1101/2020.09.15.275891"
    ],
    [
      "Nafamostat",
      "Nafamostat mesylate",
      "-",
      "Active",
      "-",
      "France/IDF0571/2020",
      "3-dimensional human airway epithelia model",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.09.16.300483"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "France/IDF0571/2020",
      "3-dimensional human airway epithelia model",
      "0.1",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.09.16.300483"
    ],
    [
      "Bromelain",
      "-",
      "-",
      "Active",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.01",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.09.16.297366"
    ],
    [
      "Bafetinib",
      "-",
      "0.79",
      "-",
      ">10",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "Sorafenib",
      "-",
      "1.4",
      "-",
      ">10",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "MLCK inhibitor peptide 18",
      "-",
      "-",
      "Inactive",
      ">10",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "ML-7",
      "-",
      "1.7",
      "-",
      "5",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "Bosutinib",
      "-",
      "0.13",
      "-",
      "0.48",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "Saracatinib",
      "-",
      "0.39",
      "-",
      "0.91",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "Dasatinib",
      "-",
      "1.1",
      "-",
      "0.04",
      "France/IDF0571/2020",
      "A549-Ace2",
      "-",
      "Plaque assay",
      "CellTiter Gloassay",
      "https://doi.org/10.1101/2020.09.16.297945"
    ],
    [
      "Nelfinavir+G614 convalescent serum",
      "-",
      "-",
      "Active",
      "-",
      "Norway/Trondheim-S15/2020",
      "\nCalu-3",
      "-",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.17.299933"
    ],
    [
      "Nelfinavir+EIDD-2801",
      "-",
      "-",
      "Active",
      "-",
      "Norway/Trondheim-S15/2020",
      "Calu-3",
      "-",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.17.299933"
    ],
    [
      "Nelfinavir+Remdesivir",
      "-",
      "-",
      "Active",
      "-",
      "Norway/Trondheim-S15/2020",
      "Calu-3",
      "-",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.17.299933"
    ],
    [
      "Remdesivir",
      "-",
      "3",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir",
      "-",
      "0.7",
      "-",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Velpatasvir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Elbasvir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Dabrafenib",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Cilostazol",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Nimodipine",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Conivaptan Hydrochloride",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Clobetasol",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Budesonide",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Drosiprenone",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Ezetimibe",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Ivosidenib",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Selexipag",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Meprednisone",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Nifedipine",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Omeprazole Sulfide",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Quinapril",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Rifaximin",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Telmisartan",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Valdecoxib",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Zafirlukast",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Velpatasvir+Sofosbuvir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Remdesivir+Elbasvir+Grazoprevir",
      "-",
      "-",
      "Synergistic",
      "-",
      "USA-WA1/2020",
      "Calu-3",
      "0.05",
      "Cytopathic effect by Cell Titer-Glo",
      "-",
      "https://doi.org/10.1101/2020.09.18.302398"
    ],
    [
      "Resveratrol",
      "-",
      "66",
      "-",
      ">150",
      "NL/2020",
      "Vero E6",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "Pterostilbene",
      "-",
      "19",
      "-",
      ">60",
      "NL/2020",
      "Vero E6",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "Resveratrol",
      "-",
      "-",
      "Inactive",
      ">50",
      "NL/2020",
      "Calu-3",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "Pterostilbene",
      "-",
      "-",
      "Inactive",
      ">60",
      "NL/2020",
      "Calu-3",
      "1",
      "Plaque assay\u00a0",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay kit\u00a0",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "Resveratrol",
      "-",
      "-",
      "Active",
      ">150",
      "NL/2020",
      "Primary human bronchial epithelium cell (PBEC) model",
      "5",
      "Plaque assay\u00a0",
      "LDH/FACS",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "Pterostilbene",
      "-",
      "-",
      "Active",
      ">60",
      "NL/2020",
      "Primary human bronchial epithelium cell (PBEC) model",
      "5",
      "Plaque assay\u00a0",
      "LDH/FACS",
      "https://doi.org/10.1101/2020.09.24.285940"
    ],
    [
      "Nitazoxanide",
      "[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate",
      "4.9",
      "-",
      ">300",
      "USA-WA1/2020",
      "Vero E6",
      "0.5",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.09.24.312165"
    ],
    [
      "JIB-04",
      "5-chloro-N-[(E)-[phenyl(pyridin-2-yl)methylidene]amino]pyridin-2-amine",
      "0.69\u00a0",
      "-",
      ">300",
      "USA-WA1/2020",
      "Vero E6",
      "0.5",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.09.24.312165"
    ],
    [
      "Remdesivir",
      "-",
      "0.05",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325316"
    ],
    [
      "Remdesivir",
      "-",
      "0.29",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Calu-1",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325316"
    ],
    [
      "Remdesivir",
      "-",
      "0.31",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325316"
    ],
    [
      "EIDD-2801 ",
      "-",
      "8.5",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325317"
    ],
    [
      "EIDD-2801 ",
      "-",
      "2.7",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Calu-1",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325318"
    ],
    [
      "EIDD-2801 ",
      "-",
      "1.3",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325319"
    ],
    [
      "Galidesivir ",
      "-",
      "48",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325320"
    ],
    [
      "Galidesivir ",
      "-",
      "58",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Calu-1",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325321"
    ],
    [
      "Galidesivir ",
      "-",
      "24",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325322"
    ],
    [
      "Sofosbuvir",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325323"
    ],
    [
      "Uprifosbuvir",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325324"
    ],
    [
      "Valopicitabine",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325325"
    ],
    [
      "Mericitabine",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325326"
    ],
    [
      "Ribavirin",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325327"
    ],
    [
      "Favipiravir",
      "-",
      ">50",
      "-",
      "-",
      "Denmark/DK-AHH1/2020",
      "Huh7.5, Calu-1, A549",
      "-",
      "Cytopathic effect",
      "MTS assay, Promega",
      "https://doi.org/10.1101/2020.10.04.325328"
    ],
    [
      "Suramin",
      "-",
      "2.9",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Suramin derivative NF023",
      "-",
      "34.1",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Suramin derivative NF110",
      "-",
      "2.87",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Suramin derivative NF157",
      "-",
      "9.52",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Suramin derivative NF279",
      "-",
      "9.26",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Suramin derivative NF449",
      "-",
      "12.99",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Suramin derivative NF546",
      "-",
      "27.4",
      "-",
      ">1000",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "Remdesivir",
      "-",
      "1.57",
      "-",
      "264",
      "Wuhan/WIV04/2019",
      "Vero E6",
      "0.01",
      "RT-qPCR",
      "CCK8 assays",
      "https://doi.org/10.1101/2020.10.06.328336"
    ],
    [
      "GNS561",
      "-",
      "0.006",
      "-",
      "2",
      "USA-WA1/2020",
      "Vero E6",
      "0.1",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "Chloroquine",
      "-",
      "0.1",
      "-",
      "73.23",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "Remdesivir",
      "-",
      "1.2",
      "-",
      ">100",
      "USA-WA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "GNS561",
      "-",
      "0.03",
      "-",
      "6.7",
      "IHU-MI3 -MI6",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.10.06.327635"
    ],
    [
      "Auranofin",
      "-",
      "~0.83",
      "-",
      "~2.2",
      "Wuhan/IVDC/-HB -01/2020 (EPI_ISL_402119)",
      "Vero E6",
      "0.015",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.10.16.342097"
    ],
    [
      "Gold Cluster",
      "-",
      "~7.32",
      "-",
      ">100",
      "Wuhan/IVDC/-HB -01/2020 (EPI_ISL_402119)",
      "Vero E6",
      "0.015",
      "RT-qPCR",
      "CCK8",
      "https://doi.org/10.1101/2020.10.16.342097"
    ],
    [
      "Itraconazole",
      "-",
      "0.43",
      "-",
      "25.56",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "Fluoxetine+Remdesivir",
      "-",
      "-",
      "Synergistic",
      "-",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "Itraconazole+Remdesivir",
      "-",
      "-",
      "Synergistic",
      "-",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Calu-3",
      "0.1",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "Itraconazole",
      "-",
      "0.39",
      "-",
      "-",
      "Germany/FI1103201/2020 113 (EPI-ISL_463008, mutation D614G in spike protein)",
      "Vero E6",
      "0.01",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.16.342410"
    ],
    [
      "Migalastat",
      "DGJ HCl, Migalastat Hydrochloride, Galafold",
      "-",
      "Active",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Entacapone",
      "Comtan",
      "-",
      "Active",
      "232",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Lucerastat",
      "NB-DGJ",
      "-",
      "Active",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Conduritol-B-epoxide",
      "CBE",
      "-",
      "Active",
      ">200",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Miglustat",
      "Zavesca, NB-DNJ",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "NN-DNJ",
      "-",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MON-DNJ",
      "UV4, UV4B",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Silmitasertib",
      "CX-4945",
      "-",
      "Active",
      "22.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Dabrafenib mesylate",
      "GSK-2118436",
      "-",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Nafamostat",
      "Nafamostat mesylate, Fusan",
      "-",
      "Active",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Nelfinavir",
      "Nelfinavir mesylate",
      "-",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Roxadustat",
      "FG4592",
      "-",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Cytopathic effect by Amido Black",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Migalastat",
      "DGJ HCl, Migalastat Hydrochloride, Galafold",
      ">1000",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Midostaurin",
      "Rydapt",
      ">1",
      "-",
      "51.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Indomethacin",
      "Indometacin",
      ">100",
      "-",
      "587",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Metformin HCl",
      "Dimethylbiguanid, Fortamet, Glucophage, Glumetza",
      ">100",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Ribavirin",
      "-",
      ">10",
      "-",
      "223",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Mycophenolic Acid",
      "Mycophenolate mofetil",
      ">0.1",
      "-",
      "1.77",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Melatonin",
      "-",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Valproic Acid",
      "Valproat, Depakene, Stavzor, Depacon",
      ">100",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Entacapone",
      "Comtan",
      "-",
      "Active",
      "232",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Verapamil",
      "S-verapamil",
      ">10",
      "-",
      "96.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Haloperidol",
      "Haldol, Serenace",
      ">100",
      "-",
      "271",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "(D)-PDMP",
      "N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-decanamide",
      "3.38",
      "Active",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "U18666a",
      "-",
      ">0.202",
      "-",
      "7.28",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Lucerastat",
      "NB-DGJ",
      "316",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Conduritol-B-epoxide",
      "CBE",
      ">200",
      "-",
      ">200",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Miglustat",
      "Zavesca, NB-DNJ",
      "170",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "NN-DNJ",
      "-",
      "4.63",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MON-DNJ",
      "UV4, UV4B",
      "24.5",
      "Active",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Daunorubicin",
      "Daunorubicin HCl, Acetyladriamycin, Daunomycin, Leukaemomycin C, Rubidomycin",
      ">0.01",
      "-",
      "0.227",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Silmitasertib",
      "CX-4945",
      "<0.771",
      "Active",
      "22.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Dabrafenib mesylate",
      "GSK-2118436",
      "-",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Enisamium",
      "FAV00A, Amizon",
      ">10",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "VR17-04",
      "-",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Tamoxifene",
      "Tamoxifen citrate, Nolvadex",
      ">1",
      "-",
      "7.09",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Raloxifene",
      "Raloxifene Hydrochloride, Estiva",
      ">1",
      "-",
      "91.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Atorvastatin",
      "Lipitor, Atorvastatin calcium",
      ">10",
      "-",
      "35.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Tacrolimus",
      "FK-506",
      ">1",
      "-",
      "12.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Clomifene",
      "Clomid, Clomifene citrate, Clomiphene",
      ">1",
      "-",
      "5.76",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Ciprofloxacin",
      "-",
      ">66.7",
      "-",
      "392",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Linezolid",
      "-",
      ">1000",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Lomitapide",
      "Juxtapid, Lojuxta",
      ">1",
      "-",
      "9.26",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Eliglustat",
      "Genz-112638, Cerdelga, Eliglustat tartrate",
      ">10",
      "-",
      "443",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "N,N-dimethylamiloride HCl",
      "-",
      ">10",
      "-",
      "92.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Dronedarone",
      "MULTAQ, Dronedarone HCl",
      ">1",
      "-",
      "38.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Tigecycline hydrate",
      "-",
      ">10",
      "-",
      "79.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Rapamycin",
      "Sirolimus, Rapamune",
      ">0.001",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Nafamostat",
      "Nafamostat mesylate, Fusan",
      "2.78",
      "Active",
      "94.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Carmofur",
      "1-hexylcarbamoyl-5-fluorouracil",
      ">0.1",
      "-",
      "67.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Chloramphenicol",
      "Chloramphenicol hydrate",
      ">1000",
      "-",
      ">1000",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Imipramine",
      "Imipramine hydrochloride",
      ">10",
      "-",
      "83",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Amiodarone",
      "Amiodarone HCl",
      ">10",
      "-",
      "28.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Lercanidipine",
      "Lercadip, Lerdip, Zanidip, Lercanidipine HCl",
      ">1",
      "-",
      "13.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Nelfinavir",
      "Nelfinavir mesylate",
      "-",
      "-",
      "41",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BIIB021",
      "CNF2024",
      ">0.01",
      "-",
      "0.348",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Teleglenastat",
      "CB-839",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "4EGI-1",
      "-",
      ">1",
      "-",
      "19.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Roxadustat",
      "FG4592",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "SR9009",
      "-",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Avasimibe",
      "-",
      ">1",
      "-",
      "9.15",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PT2385",
      "-",
      ">200",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Amiloride hydrochloride",
      "-",
      ">100",
      "-",
      "280",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "HMA",
      "5-(N,N-Hexamethylene)amiloride, Hexamethyleneamiloride",
      ">1",
      "-",
      "8.09",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "2-Deoxyglucose",
      "-",
      ">100",
      "-",
      "359",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Folic acid",
      "Vitamin B9",
      ">51.5",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MED-COV-4280ac29-15",
      "CVD-0002720",
      ">1",
      "-",
      "16.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "SIM-SYN-f15aaa3a-1",
      "CVD-0003482",
      ">1",
      "-",
      "40.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-916a2c5a-1",
      "CVD-0002706",
      ">1",
      "-",
      "42.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-916a2c5a-2",
      "CVD-0002707",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-8f408cad-3",
      "CVD-0001866",
      ">1",
      "-",
      "19.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-adc59df6-47",
      "CVD-0004255",
      ">1",
      "-",
      "38.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MED-COV-4280ac29-31",
      "CVD-0002737",
      ">1",
      "-",
      "7.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "5-Thioguanine",
      "Thioguanine, 154-42-7, Tioguanine, 2-Amino-6-mercaptopurine",
      ">1",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Antipain",
      "UNII-47V479BE6L, CCRIS 3605, EINECS 253-631-0",
      ">100",
      "-",
      "50.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Bismuth (III) Subsalicylate",
      "14882-18-9, Bismuth oxysalicylate, Wismutsubsalicylat, Bismuth oxide salicylate",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "N-p-Tosyl-L-phenylalanine chloromethyl ketone",
      "TPCK",
      ">1",
      "-",
      "17.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BAY-11 7082 ",
      "BAY 11-7821,19542-67-7,(E)-3-Tosylacrylonitrile, (E)-3-(p-Toluenesulfonyl)acrylonitrile",
      ">1",
      "-",
      "9.59",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Boceprevir",
      "Victrelis, 394730-60-0, SCH 503034, EBP 520",
      "94.2",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Auranofin",
      "2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold, (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate",
      ">1",
      "-",
      "67.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Cisplatin",
      "cis-Diaminedichloroplatinum, cis-Diamminedichlorplatine, cis-Dichlorodiamine platinum, Platinum, diamminedichloro-NCGC00090759-01",
      "92.4",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride",
      "TLCK",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "IPA 3",
      "Bis(2-hydroxy-1-naphthyl) disulfide, 1,1'-Dithiodi-2-naphthol,UNII-3XFG6MQ9G2",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "8-Hydroxy-5-nitroquinoline",
      "Nitroxoline, 5-nitroquinolin-8-ol, 4008-48-4, 5-Nitro-8-hydroxyquinoline",
      ">1",
      "-",
      "70.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "NSC95397",
      "93718-83-3, NSC-95397, 2,3-Bis(2-hydroxyethylthio)-1,4-naphthalenedione",
      ">1",
      "-",
      "8.67",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Plaque assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Toremifene",
      "Toremifene citrate, Fareston",
      ">1.67",
      "-",
      "27.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Ruxolitinib",
      "Jafaki ruxolitinib phosphate",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Celecoxib",
      "Celebrex, Onsenal, Elyxyb",
      ">10",
      "-",
      "76.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Alvelestat",
      "-",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Rivaroxiban",
      "Xarelto",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Fludarabine",
      "Fludara, 2-fluoro ARA-A",
      ">1",
      "-",
      "15.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Ambroxol",
      "Mucosolvan, Mucol Brontex",
      ">10",
      "-",
      "45.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Indinavir",
      "IDV, Crixivan",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Itraconazole",
      "-",
      ">1.325",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Olaparib",
      "LYNPARZA, AZD-2281, MK-7339",
      ">1",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PDD00017273",
      "-",
      ">5",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Talazoparib",
      "Talzenna, BMN-673",
      ">0.05",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Veliparib",
      "ABT-888",
      ">5",
      "-",
      ">10",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "NAP-DNJ",
      "-",
      "9.92",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "NN-DGJ",
      "-",
      "158",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MON-DGJ",
      "-",
      ">0.25",
      "-",
      "380",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "INFa2, Interferon alpha 2",
      "-",
      "<0.001",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "INFL4s70, Interferon lambda 4s70",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "INFL4p70, Interferon lambda 4p70",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "INFL4, Interferon lambda 4",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "INFL3, Interferon lambda 3 (Prep 1H)",
      "-",
      ">0.1 \u03bcg/mL",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "INFL3, Interferon lambda 3 (Prep 1)",
      "-",
      "<0.001",
      "Active",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-ff7b210a-4",
      "CVD-0007438",
      ">10",
      "-",
      "89",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LOR-NEU-c8f11034-5",
      "CVD-0005886",
      "15.2",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-babf2c61-1",
      "CVD-0006798",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LOR-NEU-c8f11034-2",
      "CVD-0005883",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "TRY-UNI-2eddb1ff-7",
      "CVD-0004754",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-c59291d4-5",
      "CVD-0006354",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-c59291d4-6",
      "CVD-0006355",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-d2866bdf-1",
      "CVD-0007225",
      "15.3",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JOR-UNI-2fc98d0b-12",
      "CVD-0001724",
      "14.9",
      "Active",
      "21.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Sinefungin",
      "Adenosyl-ornithine",
      ">500",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "TSF_217",
      "Lactivicin derivative,352",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PLTV",
      "Lactivicin",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BI41",
      "Penicllin sulfone derivate 1",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BI50",
      "Penicllin sulfone derivate 2",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BI71-2",
      "Penicllin sulfone derivate 3",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BI63",
      "Penicllin sulfone derivate 4",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Tenegliptin",
      "Tenelia, Teneligliptin",
      ">47.7",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Ponatinib",
      "Iclusig, AP24534",
      ">10",
      "-",
      "67.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LOR-NOR-30067bb9-7",
      "CVD-0009876",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "DAN-LON-a5fc619e-8",
      "CVD-0000654",
      ">10",
      "-",
      "77.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "DAN-LON-a5fc619e-3",
      "CVD-0000649",
      ">10",
      "-",
      "79.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-babf2c61-9",
      "CVD-0006806",
      ">10",
      "-",
      "77.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MED-COV-4280ac29-30",
      "CVD-0002736",
      ">10",
      "-",
      "87.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JAN-GHE-5a013bed-2",
      "CVD-0004611",
      ">10",
      "-",
      "104",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-6af13d92-3",
      "CVD-0005777",
      "15.3",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ADA-UCB-6c2cb422-1",
      "CVD-0007756",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-6af13d92-1",
      "CVD-0005775",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JAG-UCB-a3ef7265-20",
      "CVD-0005329",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "TAT-ENA-80bfd3e5-1; MAT-POS-e10a589d-2",
      "CVD-0008035",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-e10a589d-1",
      "CVD-0012923",
      ">1",
      "-",
      "8.97",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PAU-UNI-8cdd41c7-1",
      "CVD-0003037",
      ">10",
      "-",
      "32.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-2e27a2e5-1",
      "CVD-0010542",
      ">10",
      "-",
      "81.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "TRY-UNI-714a760b-3",
      "CVD-0003629",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "AGN-NEW-891393a6-1",
      "CVD-0000033",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-c59291d4-2",
      "CVD-0006351",
      "31.5",
      "Active",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-91609ae9-3",
      "CVD-0006189",
      ">10",
      "-",
      "86.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "DAV-CRI-14a23e73-1",
      "CVD-0000864",
      ">10",
      "-",
      "81.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BEN-DND-93268d01-8",
      "CVD-0005075",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BOLD100",
      "-",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Alendronate",
      "Fosamax, Alendronic Acid, Alendronate Sodium, Binosto",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Clodronate",
      "Clodronic Acid, Sodium Clodronate",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Zolendronate",
      "Zoledronic Acid, Zometa, Reclast",
      ">1",
      "-",
      "29.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Ox14",
      "1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)-ethyl-bisphosphonate",
      ">1",
      "-",
      "16",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Azetronam",
      "IAL-MD0005",
      ">50",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "IAL-MD0128",
      "24218528",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "IAL-MD0131",
      "40017795",
      ">50",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Quercetin",
      "Sophoretin; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one ",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-3b848b35-2",
      "CVD-0010545",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "VLA-UCB-1dbca3b4-15",
      "CVD-0012801",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Activin A",
      "-",
      ">33",
      "-",
      "-",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-c314995a-1",
      "CVD-0011943",
      ">10",
      "-",
      "12.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-11b63608-1",
      "CVD-0013197",
      ">10",
      "-",
      "26",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-9ff17035-3",
      "CVD-0012742",
      ">1",
      "-",
      "2.08",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-bbbbc21a-3",
      "CVD-0013195",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-f2460aef-3",
      "CVD-0013166",
      ">10",
      "-",
      "79.3",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-f2460aef-4",
      "CVD-0013167",
      ">1",
      "-",
      "9.79",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-f7918075-2",
      "CVD-0012962",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-fa06b69f-6",
      "CVD-0013057",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PET-UNK-1901c25b-1",
      "CVD-0013216",
      ">1",
      "-",
      "24.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-00c1612e-1",
      "CVD-0010618",
      ">1",
      "-",
      "4.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-b3e365b9-1",
      "CVD-0013192",
      "1.99",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-f2460aef-1",
      "CVD-0013164",
      "2.89",
      "-",
      "14.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-c59291d4-1",
      "CVD-0006350",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-3b92565d-1",
      "CVD-0011616",
      ">10",
      "-",
      "13.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ERI-UCB-ce40166b-17",
      "CVD-0007597",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Clofazimine",
      "Lamprene",
      ">1",
      "-",
      "39.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Niclosamide",
      "5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide",
      ">1",
      "-",
      "3.05",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Favipiravir",
      "6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Merimepodib",
      "-",
      ">1",
      "-",
      "1.02",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Nitazoxanide",
      "Alinia",
      ">1",
      "-",
      "1.57",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Daclatasvir",
      "Daklinza",
      ">10",
      "-",
      "34",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Camostate",
      "Camostat",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-8a69d52e-2",
      "CVD-0013291",
      "1.82",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-e4b030d8-2",
      "CVD-0013199",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JOH-MSK-46727e7b-1",
      "CVD-0013146",
      "3.67",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-5e7d1b3e-72",
      "CVD-0010838",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LON-WEI-5e7d1b3e-68",
      "CVD-0010835",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-6d04362c-2",
      "CVD-0012949",
      "3.76",
      "-",
      "79",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-54c4bf04-3",
      "CVD-0014251",
      ">10",
      "-",
      "72.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JOH-UNI-ea1df7a8-1",
      "CVD-0014244",
      ">1",
      "-",
      "27.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-8d5af1ef-1",
      "CVD-0014153",
      "23",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-3b536971-1",
      "CVD-0014247",
      "7.9",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-696356e4-1",
      "CVD-0014383",
      "3.23",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-53907a1c-3",
      "CVD-0013693",
      ">10",
      "-",
      "81.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-23a8a11a-1",
      "CVD-0014468",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PET-UNK-c9c1e0d8-3",
      "CVD-0011629",
      "8.97",
      "-",
      "77",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "VLA-UCB-29506327-1",
      "CVD-0014471",
      ">1",
      "-",
      "70.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-0c8fa4a7-1",
      "CVD-0013694",
      "9.08",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-477dc5b7-1",
      "CVD-0013211",
      "6.88",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-477dc5b7-2",
      "CVD-0013212",
      "2.19",
      "-",
      "68.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-8a69d52e-6",
      "CVD-0013295",
      "0.915",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-e4b030d8-13",
      "CVD-0013210",
      "1.67",
      "-",
      "74.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "PET-UNK-c9c1e0d8-4",
      "CVD-0011630",
      "3.57",
      "-",
      "74.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RBN-2397",
      "Atamparib",
      ">3.3",
      "-",
      "86.7",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RBN012759",
      "7-(cyclopropylmethoxy)-5-fluoro-2-{[(trans-4-hydroxycyclohexyl)sulfanyl]methyl}quinazolin-4(3H)-one",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-966f8da6-2",
      "CVD-0014245",
      ">33.3",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-090737b9-1",
      "CVD-0015227",
      "2.8",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "rel-EDJ-MED-12c115cc-1",
      "CVD-0014914",
      ">1",
      "-",
      "14.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-4aa06b95-1",
      "CVD-0014255",
      "35.1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-6c284e65-1",
      "CVD-0015011",
      "3.01",
      "-",
      "57.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "rac-PET-UNK-29afea89-2",
      "CVD-0015328",
      "1.01",
      "-",
      "104",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BRU-THA-92256091-17",
      "CVD-0014292",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MIC-UNK-91acba05-6",
      "CVD-0013559",
      ">1",
      "-",
      "37",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-ce760d3f-1",
      "CVD-0014502",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-2d450e86-17",
      "CVD-0015041",
      "2.89",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-2d450e86-16",
      "CVD-0015040",
      "3.32",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-2d450e86-14",
      "CVD-0015038",
      "3.03",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-869ac754-1",
      "CVD-0015012",
      "1.01",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BEN-DND-c852c98b-5",
      "CVD-0014233",
      "9.27",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-8416115c-6",
      "CVD-0014266",
      "5.91",
      "-",
      "41.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-2d450e86-6",
      "CVD-0015030",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-UNI-3735e77e-2",
      "CVD-0015022",
      "3.19",
      "-",
      "> 87.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-d91e0300-1",
      "CVD-0015066",
      "1.01",
      "-",
      "74.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "rel-PET-UNK-29afea89-2",
      "CVD-0013943",
      "0.241",
      "-",
      "59.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "rel-EDJ-MED-92e193ae-1",
      "CVD-0014805",
      "0.995",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "T-5224",
      "3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-c3a96089-4",
      "CVD-0014210",
      "5.52",
      "-",
      "22.8",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "VLA-UCB-50c39ae8-7",
      "CVD-0013309",
      "8.47",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-UNI-3735e77e-4",
      "CVD-0015024",
      "0.856",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BEN-BAS-c2bc0d80-6",
      "CVD-0014160",
      "1.04",
      "-",
      "49.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-3b97339c-2",
      "CVD-0016321",
      "0.843",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-e69ad64a-2",
      "CVD-0015332",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-d08626de-3",
      "CVD-0015340",
      ">0.1",
      "-",
      "13.4",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-37aac4bd-4",
      "CVD-0015861",
      ">0.1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-a13804f0-3",
      "CVD-0016447",
      "1.04",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-f9802937-8",
      "CVD-0015381",
      "0.843",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-a13804f0-4",
      "CVD-0016448",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-fe871b40-11",
      "CVD-0015853",
      "1.11",
      "-",
      "24.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-78e1d523-1",
      "CVD-0016254",
      "2.2",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-932d1078-3",
      "CVD-0016505",
      "0.152",
      "-",
      "37.2",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Remdesivir",
      "CVD-0016508",
      "0.549",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "Molnupiravir",
      "CVD-0016509",
      "-",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-3ccb8ef6-1",
      "CVD-0016619",
      "2.99",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "BEN-BAS-c2bc0d80-7",
      "CVD-0014161",
      "1.79",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-9e38fd34-1",
      "CVD-0015343",
      "2.92",
      "-",
      "44.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDG-MED-ba1ac7b9-9",
      "CVD-0015596",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDG-MED-5d232de5-5",
      "CVD-0015362",
      "2.47",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JNK-IN-8",
      "(E)-3-(4-(dimethylamino)but-2-enamido)-N-(3-methyl-4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide",
      ">1",
      "-",
      "1.53",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "LY3214996",
      "6,6-dimethyl-2-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-5-(2-morpholinoethyl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one",
      ">10",
      "-",
      "86",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-477dc5b7-5",
      "CVD-0013215",
      "2.83",
      "-",
      "94.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-96f51285-6",
      "CVD-0016875",
      ">0.03",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-UNI-8d415491-5",
      "CVD-0016486",
      ">100",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-a5ef2d74-2",
      "CVD-0016992",
      "1.95",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-dd3ad2b5-3",
      "CVD-0016467",
      ">10",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-UNI-8d415491-2",
      "CVD-0016483",
      "4.17",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MIC-UNK-91acba05-3",
      "CVD-0013558",
      "3.52",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-96f51285-1",
      "CVD-0016870",
      "1.35",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "JIN-POS-6dc588a4-22",
      "CVD-0016572",
      ">0.33",
      "-",
      "43.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-dd3ad2b5-4",
      "CVD-0016468",
      "3.64",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-96f51285-2",
      "CVD-0016871",
      "3.14",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-dd3ad2b5-5",
      "CVD-0016469",
      "7.91",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-96f51285-3",
      "CVD-0016872",
      ">1",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-dd3ad2b5-2",
      "CVD-0016466",
      "4.6",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-96f51285-5",
      "CVD-0016874",
      "4.04",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-993cdc78-1",
      "CVD-0016690",
      "1.02",
      "-",
      "77.9",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-UNI-8d415491-6",
      "CVD-0016487",
      "3.26",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "ALP-POS-fe871b40-16",
      "CVD-0015858",
      "1.99",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-4",
      "CVD-0016899",
      "31.9",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-25",
      "CVD-0016918",
      "4.52",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "EDJ-MED-611d11e7-4",
      "CVD-0016452",
      "0.716",
      "-",
      "40.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-6",
      "CVD-0016901",
      "1.85",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-23",
      "CVD-0016916",
      "1.56",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-ec6d90b7-6",
      "CVD-0017144",
      "0.949",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-11",
      "CVD-0016906",
      "0.944",
      "-",
      "91.5",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-9",
      "CVD-0017253",
      "6.79",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-2",
      "CVD-0016897",
      "0.989",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-12",
      "CVD-0016907",
      "1.6",
      "-",
      "94.1",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MIC-UNK-91acba05-1",
      "CVD-0013556",
      "10.2",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-3",
      "CVD-0016898",
      "3.59",
      "-",
      "> 82.6",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-31",
      "CVD-0016924",
      "4.26",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "RAL-THA-6e4c80cf-1",
      "CVD-0016844",
      "1.85",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-41",
      "CVD-0016934",
      "7.62",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-18",
      "CVD-0016913",
      "3.05",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-40",
      "CVD-0016933",
      "3.27",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-1",
      "CVD-0016896",
      "4.7",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "MAT-POS-4223bc15-39",
      "CVD-0016932",
      "2.55",
      "-",
      ">100",
      "England02/2020",
      "Calu-3",
      "0.5",
      "Focus Forming Assay",
      "CellTiter 96\u00ae AQueous One Solution Cell Proliferation Assay (MTS)",
      "http://sarscov2.assaytracker.net/results/"
    ],
    [
      "P7 SALEE QYKTF LDKFL HELED LLYQL ALAL-NH2",
      "-",
      "7 / 6.8",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "P8 SALEE QLKTF LDKFM HELED LLYQL AL-NH2",
      "-",
      "0.8 / 0.09",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "P9 SALEE QYKTF LDKFM HELED LLYQL SL-NH2",
      "-",
      "0.3 / 0.07",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "P10 SALEE QYKTF LDKFM HELED LLYQL AL-NH2",
      "-",
      "0.06 / 0.08",
      "-",
      "-",
      "SARS-CoV-2 clinical isolate (SABA95 P2 stock)",
      "VeroE6, Calu3",
      "0.1/ 0.3",
      "Plaque assay",
      "MTT assays",
      "https://doi.org/10.1101/2020.08.24.264077"
    ],
    [
      "AHB1",
      "-",
      "0.035",
      "-",
      "-",
      "SARS-CoV-2 strain 2019 n-CoV/USA_WA1/2020",
      "Vero E6",
      "100 FFU",
      "Immunoimaging ",
      "-",
      "https://doi.org/10.1101/2020.08.03.234914"
    ],
    [
      "LCB1",
      "-",
      "34.46pM",
      "-",
      "-",
      "SARS-CoV-2 strain 2019 n-CoV/USA_WA1/2020",
      "Vero E6",
      "100 FFU",
      "Immunoimaging ",
      "-",
      "https://doi.org/10.1101/2020.08.03.234914"
    ],
    [
      "LCB3",
      "-",
      "48.1pM",
      "-",
      "-",
      "SARS-CoV-2 strain 2019 n-CoV/USA_WA1/2020",
      "Vero E6",
      "100 FFU",
      "Immunoimaging ",
      "-",
      "https://doi.org/10.1101/2020.08.03.234914"
    ],
    [
      "ACIS KEpTide\u2122",
      "-",
      "-",
      "active",
      "-",
      "Vero E6",
      "SARS-CoV2 (SARS CoV-2 USA_WA1/2020)",
      "01/fev",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.13.337584"
    ],
    [
      "merafloxacin",
      "CI-934",
      "2.6",
      "-",
      "not toxic",
      "Vero E6",
      "SARS-CoV-2",
      "5",
      "Plaque assay",
      "ATP prod/ LDH",
      "https://doi.org/10.1101/2020.10.21.349225"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "active",
      "-",
      "Primary nHTBE",
      "SARS-CoV-2 strain 2019-nCoV/USA_WA1/2020",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2020.10.19.343954"
    ],
    [
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "0.074",
      "-",
      "-",
      "Vero E6",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "Cytopathic effect",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "<0.080",
      "-",
      "-",
      "A549/ACE2",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "Cytopathic effect",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "0.004",
      "-",
      "-",
      "HeLa/ACE2",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "Cytopathic effect",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "5.5",
      "-",
      "-",
      "Calu-3",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "1",
      "Immunofluorescence",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "K777",
      "K11777, S-001, SLV213, 4-methyl-N-((S)-1-oxo-3-phenyl-1-(((S)-1-phenyl-5- (phenylsulfonyl)pentan-3-yl)amino)propan-2-yl)piperazine-1-carboxamide)",
      "4.3",
      "-",
      "-",
      "Caco-2",
      "SARS-CoV-2 (USA_WA1/2020 isolate",
      "-",
      "-",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.23.347534"
    ],
    [
      "GS-441524",
      "parent nucleotide of Remdesivir",
      "0.7",
      "-",
      ">50",
      "Vero E6",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "CCK8",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "GS-441524",
      "parent nucleotide of Remdesivir",
      "3.21",
      "-",
      ">50",
      "calu-3",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "CCK8",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "GS-441524",
      "parent nucleotide of Remdesivir",
      "3.62",
      "-",
      ">50",
      "caco-2",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "CCK8",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "Remdesivir",
      "-",
      "1.35",
      "-",
      "-",
      "Vero E6",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "Remdesivir",
      "-",
      "0.65",
      "-",
      "-",
      "calu-3",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "Remdesivir",
      "-",
      "0.58",
      "-",
      "-",
      "caco-2",
      "Patient-derived SARS-CoV-2",
      "0.05",
      "qRT-PCR",
      "-",
      "http://biorxiv.org/cgi/content/short/2020.10.26.353300"
    ],
    [
      "Simeprevir ",
      "-",
      "1.40 \u00b1 0.09",
      "-",
      "18.58",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "Cinacalcet ",
      "-",
      "2.93 \u00b1 0.38",
      "-",
      "21.23",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "Ethacridine  ",
      "-",
      "0.08\u00b1 0.01",
      "-",
      ">40",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "ABT-199 (Venetoclax) ",
      "Venetoclax",
      "1.18 \u00b1 0.12",
      "-",
      "20.56",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "Hydroxyprogesterone Cell viability (%) EC50 = 2.77 \u00b1 0.49 \"M CC50 ",
      "-",
      "2.77 \u00b1 0.49",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "Remdesivir ",
      "-",
      "0.52 \u00b1 0.09",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "Ethacridine  ",
      "-",
      "-",
      "active",
      "-",
      "primary human nasal epithelial cells",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "Ethacridine  ",
      "-",
      "-",
      "active",
      "-",
      "A549",
      "SARS-CoV-2 (USA-WA1/2020, BEI Cat No: NR-52281",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.28.359042;"
    ],
    [
      "5-amino levulinic acid",
      "5-ALA",
      "570",
      "-",
      "-",
      "VeroE6",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.002",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "5-amino levulinic acid/Sodium ferrous citrate",
      "5-ALA/SFC",
      "695",
      "-",
      "-",
      "VeroE6",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.002",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "5-amino levulinic acid",
      "5-ALA",
      "39",
      "-",
      "-",
      "Caco-2",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.02",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "5-amino levulinic acid/Sodium ferrous citrate",
      "5-ALA/SFC",
      "63",
      "-",
      "-",
      "Caco-2",
      "SARS-CoV-2(JPN/NGS/IA-1/2020 GISAID accession no. EPI-ISL481251)",
      "0.02",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2020.10.28.355305"
    ],
    [
      "Maduramycin",
      "-",
      "0.078",
      "-",
      "31",
      "Vero E6",
      "SARS-CoV-2 (IVCAS 6.7512)",
      "0.05",
      "qRT-PCR",
      "CCK-8 assays",
      "https://doi.org/10.1101/2020.10.27.354563"
    ],
    [
      "CP-80,219",
      "-",
      "0.009",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2 (IVCAS 6.7512)",
      "0.05",
      "qRT-PCR",
      "CCK-8 assays",
      "https://doi.org/10.1101/2020.10.27.354563"
    ],
    [
      "Brilacidin",
      "-",
      "~10",
      "-",
      "> 40",
      "Vero E6",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.1",
      "Plaque assay",
      "CellTitreGlo",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "Brilacidin",
      "-",
      "0.565",
      "-",
      "241",
      "calu-3",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.05",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "Brilacidin/Favipiravir",
      "-",
      "-",
      "not synergistic inhibition",
      "-",
      "calu-3",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.05",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "Brilacidin/Remdesivir",
      "-",
      "-",
      "synergistic inhibition",
      "-",
      "calu-3",
      "SARS-CoV-2(Washington strain 2019-nCoV/USA-WA1/2020)",
      "0.05",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.10.29.352450"
    ],
    [
      "GSK717",
      "-",
      "-",
      "active",
      "-",
      "-",
      "ACE2-SK-N-SH (neuroblastoma)",
      "0.05-5",
      "Plaque assay",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.11.05.370767"
    ],
    [
      "GSK583",
      "-",
      "-",
      "active",
      "-",
      "-",
      "ACE2-SK-N-SH (neuroblastoma)",
      "0.05-5",
      "Plaque assay, qRT-PCR",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.11.05.370767"
    ],
    [
      "GSK583",
      "-",
      "-",
      "active",
      "-",
      "-",
      "Calu-3, Huh7",
      "-",
      "Plaque assay",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2020.11.05.370767"
    ],
    [
      "Thymol",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "Carvacrol",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "Hesperidin",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "Thymoquinone",
      "-",
      "-",
      "active",
      "-",
      "Sars-Cov-2, patient derived",
      "Vero E6",
      "-",
      "Plaque reduction assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.07.367649"
    ],
    [
      "Ponatinib ",
      "-",
      "1.1\u00b1 0.2 ",
      "-",
      "8.7 \u00b1 3.8",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Carbenoxolone",
      "-",
      " 66 \u00b111 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Lurasidone ",
      "-",
      "18.0 \u00b1 4.6 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Elbasvir ",
      "-",
      "23.0 \u00b1 3.6 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Teniposide ",
      "-",
      "97.0 \u00b1 0.7",
      "-",
      " >100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Venetoclax  ",
      "-",
      "6.2 \u00b1 0.6",
      "-",
      "22.0\u00b1 6.2",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Irinotecan ",
      "-",
      "85.2 \u00b1 17.0 ",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Simeprevir ",
      "-",
      "9.3 \u00b1 2.0 ",
      "-",
      "47.5 \u00b1 41.0",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Grazoprevir ",
      "-",
      "16.0 \u00b1 5.7",
      "-",
      " >100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Natamycin  ",
      "-",
      "24.3 \u00b1 4.4",
      "-",
      "35.9\u00b1 13.4",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Suramin  ",
      "-",
      "64.0\u00b1 6.6",
      "-",
      ">100",
      "SARS-CoV-2 ICGEB-FVG_5",
      "Huh7-hACE2",
      "0.1",
      "Immunofluorescence",
      "DAPI staining",
      "https://doi.org/10.1101/2020.11.12.379958"
    ],
    [
      "Stenoparib",
      "-",
      "-",
      "active",
      ">60uM",
      "SARS-CoV-2 (USA-WA1/2020)",
      "Calu-3",
      "0.04",
      "RT-qPCR, Plaque assay",
      "CytoTox 96\u2122",
      "https://doi.org/10.1101/2020.11.12.380394"
    ],
    [
      "Stenoparib",
      "-",
      "-",
      "-",
      "toxic",
      "SARS-CoV-2 (USA-WA1/2020)",
      "Vero E6",
      "-",
      "-",
      "CytoTox 96\u2122",
      "https://doi.org/10.1101/2020.11.12.380394"
    ],
    [
      "Itraconazole",
      "-",
      "2.3",
      "-",
      ">50",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "0.01",
      "MTT",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "Itraconazole",
      "-",
      "1.5",
      "-",
      "-",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "-",
      "CPE visual read-out",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "Itraconazole,-17-OH",
      "-",
      "3.6",
      "-",
      ">100",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "0.01",
      "MTT",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "Itraconazole,-17-OH",
      "-",
      "1.2",
      "-",
      "-",
      "SARS-CoV-2-FFM1 (strain hCoV-19/Germany/FrankfurtFFM1/2020)",
      "Caco-2",
      "-",
      "CPE visual read-out",
      "-",
      "https://doi.org/10.1101/2020.11.13.381194"
    ],
    [
      "Rhodomyrtone",
      "-",
      "0.44",
      "-",
      "-",
      "SARS-CoV-2/Guangdong/20SF014",
      "Vero E6",
      "-",
      "CPE ",
      "-",
      "https://doi.org/10.1101/2020.11.14.382770"
    ],
    [
      "Remdesivir",
      "-",
      "0.72",
      "-",
      "-",
      "SARS-CoV-2/Guangdong/20SF014",
      "Vero E6",
      "-",
      "CPE ",
      "-",
      "https://doi.org/10.1101/2020.11.14.382770"
    ],
    [
      "Hypothiocyanite",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (Genbank: MW000351)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTT Cell 335 Proliferation Assay",
      "https://doi.org/10.1101/2020.11.17.387571"
    ],
    [
      "Hypothiocyanite/lactoferrin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (Genbank: MW000351)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTT Cell 335 Proliferation Assay",
      "https://doi.org/10.1101/2020.11.17.387571"
    ],
    [
      "Imatinib",
      "-",
      "2.5",
      "-",
      ">40",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "Masitinib",
      "-",
      "2.3",
      "-",
      "26.3",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "Asciminib",
      "-",
      "19.6",
      "-",
      "21.7",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "Remdesivir",
      "-",
      "1.2",
      "-",
      ">20",
      "SARS-CoV-2 strain BavPat1",
      "Vero E6",
      "-",
      "RT-qPCR",
      "CellTiter Blue",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "Imatinib",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain BavPat1",
      "bronchial epithelium",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.17.386904"
    ],
    [
      "PolyP120",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 viral particles Italian patient",
      "Vero E6, Caco2 and human primary nasal epithelial cells",
      "-",
      "RT-qPCR,Immunoblotting",
      "-",
      "https://doi.org/10.1101/2020.11.18.388413"
    ],
    [
      "Mefloquine",
      "-",
      "1.28",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "1.94",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "Primaquine",
      "-",
      "2.47",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "Quinine",
      "-",
      "14.9",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "Quinidine",
      "-",
      "3.68",
      "-",
      "> 16",
      "SARS-CoV-2",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.11.19.389726"
    ],
    [
      "CR-31-B (-)",
      "-",
      "~0.018",
      "-",
      ">0.1",
      "SARS-CoV-2",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "CR-31-B (-)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "human bronchial epithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "Silvestrol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "human bronchial epithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "CR-31-B (+)",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2",
      "human bronchial epithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2020.11.24.389627"
    ],
    [
      "Niclosamide ",
      "-",
      "1.1",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Penfluridol ",
      "-",
      "2.6",
      "-",
      "19",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Digoxin  ",
      "-",
      "0.6",
      "-",
      "55",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Metergoline  ",
      "-",
      "3.7",
      "-",
      "40",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Imatinib ",
      "-",
      "5",
      "-",
      "91",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Efloxate ",
      "-",
      "12.7",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Ebastine  ",
      "-",
      "5.2",
      "-",
      "45",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Protoporphyrin IX ",
      "-",
      "0.1",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Mycophenolate mofetil  ",
      "-",
      "3.6",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Pimozide  ",
      "-",
      "3.9",
      "-",
      "21",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Lanatoside C  ",
      "-",
      "0.1",
      "-",
      "80",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Cepharantine  ",
      "-",
      "1",
      "-",
      "20",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Clofazimine  ",
      "-",
      "2.8",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Remdesivir   ",
      "-",
      "1.6",
      "-",
      ">100",
      "SARS-CoV-2 strain NL/2020",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "MTT",
      "https://doi.org/10.1101/2020.11.26.399436"
    ],
    [
      "Nitazoxanide, Ribavirin, and HydroxyChloroquine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/WA/20/01",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.399055"
    ],
    [
      "Lapatinib",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate, Hong Kong/VM20001061/2020",
      "MRC5-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.398859"
    ],
    [
      "17-AAG",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate, Hong Kong/VM20001061/2020",
      "MRC5-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.398859"
    ],
    [
      "Doramapimod",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate, Hong Kong/VM20001061/2020",
      "MRC5-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2020.11.25.398859"
    ],
    [
      "Emetine",
      "-",
      "0.000147",
      "-",
      "1.6038",
      "SARS-CoV-2 (Accession Number VTCCAVA294)",
      "Vero",
      "-",
      "Plaque assay",
      "MTT",
      "https://doi.org/10.1101/2020.11.29.401984"
    ],
    [
      "Boceprevir  ",
      "-",
      "44",
      "-",
      "> 1214",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Telaprevir ",
      "-",
      "40",
      "-",
      "> 432",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Narlaprevir  ",
      "-",
      "37",
      "-",
      "269",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Simeprevir  ",
      "-",
      "15",
      "-",
      "59",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Paritaprevir  ",
      "-",
      "22",
      "-",
      "123",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Grazoprevir  ",
      "-",
      "42",
      "-",
      "239",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Glecaprevir ",
      "-",
      "> 178 ",
      "-",
      "> 268",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Voxilaprevir  ",
      "-",
      "> 41",
      "-",
      "72",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Vaniprevir  ",
      "-",
      "51",
      "-",
      "171",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Danoprevir  ",
      "-",
      "87",
      "-",
      "> 243",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Deldeprevir  ",
      "-",
      "> 20",
      "-",
      "56",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Asunaprevir  ",
      "-",
      "72",
      "-",
      "263",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Faldapreir ",
      "-",
      "23",
      "-",
      "246",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "ACH-806  ",
      "-",
      "46",
      "-",
      "> 429",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "VeroE6",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Boceprevir  ",
      "-",
      "21",
      "-",
      "701",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Simeprevir  ",
      "-",
      "14",
      "-",
      "33",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Grazoprevir  ",
      "-",
      "20",
      "-",
      "133",
      "SARS-CoV-2/human/Denmark/DK-AHH1/2020",
      "Huh7.5",
      "-",
      "Immunostaining",
      "CellTiter 96 Aqueous One Solution Cell Proliferation Assay",
      "https://doi.org/10.1101/2020.12.02.408112"
    ],
    [
      "Pyronaridine",
      "-",
      "0.198",
      "-",
      "-",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Quinacrine",
      "-",
      "0.122",
      "-",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Tilorone",
      "-",
      "0.18",
      "-",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Remdesivir",
      "-",
      "0.147",
      "-",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-ACE2",
      "-",
      "Nano-Glo Luciferase assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Quinacrine hydrochloride",
      "-",
      "> 7.33 ",
      "-",
      "7.33",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Tilorone dihydrochloride",
      "-",
      "6.62",
      "-",
      "49.64",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Pyronaridine tetraphosphate",
      "-",
      "> 3.52 ",
      "-",
      "3.52",
      "SARSCoV-2 (strain USA_WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Quinacrine hydrochloride",
      "-",
      "10.54",
      "-",
      "229.15",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Tilorone dihydrochloride",
      "-",
      "28.96",
      "-",
      "111.49",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Pyronaridine tetraphosphate",
      "-",
      "5.49",
      "-",
      "51.65",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Tilorone dihydrochloride",
      "-",
      "10.77",
      "-",
      "19.87",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Pyronaridine tetraphosphate",
      "-",
      ">50",
      "-",
      "6.49",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "Quinacrine hydrochloride",
      "-",
      ">50",
      "-",
      "7.63",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "Immunostaining",
      "-",
      "https://doi.org/10.1101/2020.12.01.407361"
    ],
    [
      "GC376",
      "-",
      "1.51",
      "-",
      "> 125",
      "SARS-CoV-2 (USA-WA1/2020 isolate)",
      "Vero E6",
      "-",
      "Immunofluorescence assay",
      "-",
      "https://doi.org/10.1101/2020.12.19.423537"
    ],
    [
      "23R",
      "-",
      "1.27",
      "-",
      "> 78.7",
      "SARS-CoV-2 (USA-WA1/2020 isolate)",
      "Vero E6",
      "-",
      "Immunofluorescence assay",
      "-",
      "https://doi.org/10.1101/2020.12.19.423537"
    ],
    [
      "23R",
      "-",
      "3.03",
      "-",
      ">100",
      "SARS-CoV-2 (USA-WA1/2020 isolate)",
      "Calu-3",
      "-",
      "Immunofluorescence assay",
      "-",
      "https://doi.org/10.1101/2020.12.19.423537"
    ],
    [
      "Glycyrrhizin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "-",
      "Plaque assay, RT-qPCR",
      "-",
      "https://doi.org/10.1101/2020.12.18.423104"
    ],
    [
      "Ivermectin",
      "-",
      "2.3",
      "-",
      "-",
      "SARS-CoV-2/Human/Liverpool/REMRQ0001/2020",
      "VERO E6",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.23.424232"
    ],
    [
      "Remdesivir",
      "-",
      "1.9",
      "-",
      "-",
      "SARS-CoV-2/Human/Liverpool/REMRQ0001/2020",
      "VERO E6",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.23.424232"
    ],
    [
      "Ivermectin+Remdesivir",
      "-",
      "-",
      "synergistic interaction",
      "-",
      "SARS-CoV-2/Human/Liverpool/REMRQ0001/2020",
      "VERO E6",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.23.424232"
    ],
    [
      "Gallinamide A analogue 19",
      "-",
      "0.168",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "Gallinamide A analogue 23",
      "-",
      "0.92",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "Gallinamide A analogue 17",
      "-",
      "6.07",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "Gallinamide A analogue 20",
      "-",
      ">5",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "Gallinamide A",
      "-",
      "0.028",
      "-",
      "-",
      "SARS-CoV-2 viral particles (USA_WA1/2020 isolate)",
      "VeroE6",
      "-",
      "CPE high content fluorescence microscopy",
      "Alamar 403 Blue HS",
      "https://doi.org/10.1101/2020.12.23.424111"
    ],
    [
      "Berberine",
      "-",
      "9.1",
      "-",
      ">150",
      "SARS-CoV-2 (BavPat1 isolate)",
      "Vero E6",
      "-",
      "Plaque assay",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "Obatoclax",
      "-",
      "0.067",
      "-",
      "7.8",
      "SARS-CoV-2 (BavPat1 isolate)",
      "Vero E6",
      "-",
      "Plaque assay",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "Berberine",
      "-",
      "23.2",
      "-",
      "-",
      "SARS-CoV2/human/Nijmegen/1/2020",
      "Vero E6",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "Obatoclax",
      "-",
      "<0.040",
      "-",
      "-",
      "SARS-CoV2/human/Nijmegen/1/2020",
      "Vero E6",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "Berberine",
      "-",
      "10.7",
      "-",
      "87.3",
      "SARS-CoV-2 (BavPat1 isolate)",
      "primary nasal epithelial cells",
      "-",
      "qRT-PCR",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "Obatoclax",
      "-",
      "0.2",
      "-",
      "6.5",
      "SARS-CoV-2 (BavPat1 isolate)",
      "primary nasal epithelial cells",
      "-",
      "qRT-PCR",
      "Cell Titer Glo 2.0 kit",
      "https://doi.org/10.1101/2020.12.23.424189"
    ],
    [
      "Losartan",
      "-",
      "13.65",
      "-",
      "-",
      "SARS-CoV-2 (2019-nCoV/USA-WA1/2020; MN985325.1)",
      "Vero E6",
      "-",
      "-",
      "-",
      "https://doi.org/10.1101/2020.12.27.424507"
    ],
    [
      "Dinaciclib",
      "-",
      "0.08",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Remdesivir",
      "-",
      "0.7",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "AZD5438",
      "-",
      "3.18",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "GC376 sodium",
      "-",
      "4.11",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "SC66",
      "-",
      "5.51",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "BFH772",
      "-",
      "7.34",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Camostat mesylate",
      "-",
      "8.57",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "B02",
      "-",
      "8.81",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "GKT137831",
      "-",
      "11.1",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Cantharidin",
      "-",
      "19.2",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Budesonide",
      "-",
      "20.5",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Cyclosporin A",
      "-",
      "25",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "CCT196969",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "TP0903",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "KC7F2",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "AT9283",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "APY29",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Tulipalin A",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Bis(3-aminopropyl)- amine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "JNK-IN-7",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Levistilide A",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "PF-562271",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "AZD9496",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "RGB-286638 free base",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Idazoxan hydrochloride",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Ginkgolic acid C15:1",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Sulbentine",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Lansoprazole",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "JNK-IN-8",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "EsOmeprazole Magnesium",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Lansoprazole",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Exemestane",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Celecoxib",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Calcitriol",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "(R)-Ruxolitinib",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Trilostane",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Disulfiram",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Dasabuvir",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Megestrol acetate",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Atracurium besylate",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Efavirenz",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Progesterone",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Ethoxzolamide",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Drospirenone",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Tretinoin",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Dabrafenib",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Grazoprevir",
      "-",
      "-",
      "not active <10uM",
      "-",
      "SARS-CoV-2, USA-WA1/2020 strain",
      "Calu-3",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2020.12.30.424862"
    ],
    [
      "Fenofibrate",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 strain hCOV-19/England/2/2020",
      "VeroE6",
      "-",
      "immunoimmaging",
      "-",
      "https://doi.org/10.1101/2021.01.10.426114"
    ],
    [
      "JQ1",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (BetaCoV/France/IDF0372/2020 strain)",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.19.427194;"
    ],
    [
      "ABBV-744",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (BetaCoV/France/IDF0372/2020 strain)",
      "Calu-3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.19.427194;"
    ],
    [
      "Exebryl-1",
      "-",
      "10",
      "-",
      "52",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "Piroxantrone",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "MMV1580853",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Vero 76",
      "-",
      "CPE",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "Exebryl-1",
      "-",
      "-",
      "-",
      "61",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Caco-2",
      "-",
      "VYR assay",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "Exebryl-1",
      "-",
      "65.6",
      "-",
      ">200",
      "SARS-CoV-2 (isolate USA WA1/2020)",
      "Calu-3",
      "-",
      "immunostaining",
      "-",
      "https://doi.org/10.1101/2021.01.21.427657"
    ],
    [
      "Sirolimus",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "Metformin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "N-hydroxycytidine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "Chloroquine",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "Dexamethasone",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain UF-1)",
      "human lung microtissues",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.01.20.427541"
    ],
    [
      "4beta-hydroxycholesterol",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "22(S)-hydroxycholesterol",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "22(R)-hydroxycholesterol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "24(S)-hydroxycholesterol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "27-hydroxycholesterol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "Oxysterol analogues",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Wk-521 strain",
      "VeroE6/TMPRSS2",
      "-",
      "qRT-PCR",
      "MTT assay",
      "https://doi.org/10.1101/2021.01.31.429001"
    ],
    [
      "Compound 1",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2",
      "Caco-2",
      "-",
      "qRT-PCR, Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.05.429959"
    ],
    [
      "GRL0617",
      "-",
      "21.7",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "XR8-23",
      "-",
      "2.8",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "XR8- 24",
      "-",
      "2.5",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "XR8- 89",
      "-",
      "11.3",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "VeroE6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "GRL0617",
      "-",
      ">20",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "A549-hACE2 c",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "XR8-23",
      "-",
      "1.4",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "A549-hACE2 c",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "XR8- 24",
      "-",
      "1.2",
      "-",
      "-",
      "SARS-CoV-2 (SARS-CoV2, Isolate USA-WA1/2020)",
      "A549-hACE2 c",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.02.13.431008"
    ],
    [
      "Azacytidine,5-",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Plerixafor",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Mebrofenin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Mavorixafor(trihydrochloride)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Plerixafor (octahy- 137drochloride) ",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Gliclazide",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Cyclen",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Kasug-138 amycin (hydrochloride hydrate)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Saroglitazar Magne- 139 sium",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "Memantine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate Israel 400 Jerusalem-854/2020",
      "Vero E6",
      "0.001-0.005",
      "(RT)-PCR",
      "MTT",
      "https://doi.org/10.1101/2021.02.24.432490"
    ],
    [
      "SNX-5422",
      "-",
      "0.38",
      "-",
      "91.97",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Vero E6",
      "0.01-0.02",
      "qRT-PCR",
      "flow cytometry",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "SNX-5422",
      "-",
      "0.4",
      "-",
      ">100",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Calu-3",
      "0.01-0.02",
      "qRT-PCR",
      "flow cytometry",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "SNX-5422",
      "-",
      "0.2",
      "-",
      "-",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Vero E6",
      "0.01-0.02",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "SNX-5422",
      "-",
      "0.2",
      "-",
      "-",
      "SARS-CoV-2 strain USA-WA1/2020",
      "Calu-3",
      "0.01-0.02",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.02.23.432479"
    ],
    [
      "WIN 55,212-2",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV-2 (GenBank accession no. MT710714)",
      "iPSC-derived cardiomyocytes",
      "0.1",
      "pcr, immunifluorescence,ELISA",
      "LDH",
      "https://doi.org/10.1101/2021.02.20.431855"
    ],
    [
      "NE-100",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (GenBank accession no. MT710714)",
      "iPSC-derived cardiomyocytes",
      "0.1",
      "Plaque assay, immunifluorescence",
      "LDH",
      "https://doi.org/10.1101/2021.02.20.432092"
    ],
    [
      "SF2523",
      "-",
      "1.52",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      " UNCN1T",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "Remdesivir",
      "-",
      "1.06",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      " UNCN1T",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "SF2523+ Remdesivir",
      "-",
      "0.62",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      " UNCN1T",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "SF2523",
      "-",
      "1.02",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      "Vero-STAT1 knockout",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "Remdesivir",
      "-",
      "1.03",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      "Vero-STAT1 knockout",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "SF2523+ Remdesivir",
      "-",
      "1.21",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020",
      "Vero-STAT1 knockout",
      "0.1",
      "RT-QPCR",
      "-",
      "https://doi.org/10.1101/2021.03.02.433604"
    ],
    [
      "6-formylindolo(3,2-b)carbazole (FICZ)",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV2/JP/Hiroshima-46059T/2020",
      "Vero E6/TMPRSS2",
      "0.01",
      "Immunoblotting analysis",
      "-",
      "https://doi.org/10.1101/2021.03.04.433658"
    ],
    [
      "Omeprazole (OMP)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV2/JP/Hiroshima-46059T/2020",
      "Vero E6/TMPRSS2",
      "0.01",
      "Immunoblotting analysis",
      "-",
      "https://doi.org/10.1101/2021.03.04.433658"
    ],
    [
      "Cobicistat",
      "-",
      "0.58-8.76",
      "-",
      "38.66-53",
      " SARS-CoV-2,BavPat1/2020",
      "Calu-3, Vero E6, T84",
      "-",
      "qPCR",
      "MTT",
      "https://doi.org/10.1101/2021.03.09.434219;"
    ],
    [
      "Cobicistat + Remdesivir",
      "-",
      "-",
      " active",
      "-",
      " SARS-CoV-2,BavPat1/2021",
      "Vero E6, T84",
      "0.5",
      "qPCR",
      "MTT",
      "https://doi.org/10.1101/2021.03.09.434219;"
    ],
    [
      "Cannabidiol",
      "-",
      "1.27",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "Cannabidiol",
      "-",
      "4.96",
      "-",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "0.1",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "7-OH-CBD",
      "-",
      "3.6",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "URMC-099",
      "-",
      "0.21",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "KPT-9274",
      "-",
      "2.14",
      "-",
      "-",
      "SARS-CoV-2",
      "A549-ACE2",
      "0.5",
      "immuno-imaging",
      "-",
      "https://doi.org/10.1101/2021.03.10.432967"
    ],
    [
      "Ebselen",
      "-",
      "4.67",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "Ebselen derivative MR6-7-2",
      "-",
      "4.5",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "Ebselen derivative MR6-18-4",
      "-",
      "3.74",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "Ebselen derivative MR6-26-2",
      "-",
      "3.17",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "Ebselen derivative MR6-31-2",
      "-",
      "1.78",
      "-",
      "-",
      "SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019)",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CCK8",
      "https://doi.org/10.1101/2021.03.11.434764"
    ],
    [
      "Apabetalone",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "JQ1",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "Camostat",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (strain BEI_USA-WA1/2020) w",
      "Calu-3",
      "0.1",
      "Immunofluorescence images",
      "-",
      "https://doi.org/10.1101/2021.03.10.432949"
    ],
    [
      "Clomipramine",
      "-",
      "4.4",
      "-",
      "-",
      "SARS-CoV-2 strain JPN/TY/WK-521",
      "Vero E6/TMPRSS2",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2021.03.13.435221"
    ],
    [
      "Ibudilast",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain JPN/TY/WK-521",
      "Vero E6/TMPRSS2",
      "-",
      "qRT-PCR",
      "-",
      "https://doi.org/10.1101/2021.03.13.435221"
    ],
    [
      "Epigallocatechin Gallate",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (isolate USA-WA1/2020, NR-52281) a",
      "Calu-3",
      "-",
      "Plaque assay, RT-qPCR",
      "MTS assay",
      "https://doi.org/10.1101/2021.03.17.435637"
    ],
    [
      "Diclazuril",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "Lenvatinib",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "Lenvatinib+Remdesivir",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "Ramelteon",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "Oprea1",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2/human/Switzerland/ZH-395-UZH-IMV5/2020",
      "Vero-CCL81",
      "0.01",
      "Plaque assay",
      "CellTiterGlo",
      "https://doi.org/10.1101/2021.03.19.435806"
    ],
    [
      "Acriflavine",
      "-",
      "0.064",
      "-",
      "3.4",
      "SARS-CoV-2 strain 026V-03883",
      "Vero-CCL81",
      "-",
      "RT-qPCR",
      "XTT",
      "https://doi.org/10.1101/2021.03.20.436259"
    ],
    [
      "Acriflavine",
      "-",
      "0.086",
      "-",
      "3.1",
      "SARS-CoV-2 strain 026V-03883",
      "A549-ACE2+",
      "-",
      "RT-qPCR",
      "XTT",
      "https://doi.org/10.1101/2021.03.20.436259"
    ],
    [
      "Acriflavine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 strain 026V-03883",
      "Human airway epithelial (HAE)",
      "-",
      "RT-qPCR",
      "XTT",
      "https://doi.org/10.1101/2021.03.20.436259"
    ],
    [
      "Halofuginone",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Hep3B",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginone",
      "-",
      "-",
      " active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2021",
      "primary human bronchial epithelial cells",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginone",
      "-",
      "0.109",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2022",
      "Huh 7.5",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginone",
      "-",
      "0.013",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2023",
      "Vero E6",
      "-",
      " Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginone",
      "-",
      "0.0349",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2024",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginone, 2R,3S-(+)",
      "-",
      "0.012",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2024",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginone, 2S,3R-(-) ",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2024",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "ProSA",
      "-",
      "2.4",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2025",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "Halofuginol",
      "-",
      "0.672",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2026",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.22.436522"
    ],
    [
      "MS023",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 isolate RIM-1 (GenBank accession number: MW599736) a",
      "VeroE6",
      "-",
      "RT-qPCR",
      "MTT",
      "https://doi.org/10.1101/2021.03.24.436822"
    ],
    [
      "Sulforaphane",
      "-",
      "2.4",
      "-",
      "-",
      "SARS-CoV-2/Wuhan-Hu-1",
      "Caco-2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.03.25.437060"
    ],
    [
      "Galidesivir",
      "-",
      "16.5-106.5",
      "-",
      "-",
      "SARS-CoV-2 PHE2/GLA1",
      "VeroE6-ACE2/A549-NPro-ACE2",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.03.25.436935"
    ],
    [
      "Remdesivir",
      "-",
      "0.07-3.17",
      "-",
      "-",
      "SARS-CoV-2 PHE2/GLA2",
      "VeroE6-ACE2/A549-NPro-ACE3",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.03.25.436935"
    ],
    [
      "HydroxyChloroquine",
      "-",
      "9.24-24.11",
      "-",
      "-",
      "SARS-CoV-2 PHE2/GLA3",
      "VeroE6-ACE2/A549-NPro-ACE4",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.03.25.436935"
    ],
    [
      "Supramolecular cylinders, [M2L3]4+ 266 (M=Ru, Ni)",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 virus England 2",
      "Vero cells",
      "-",
      "immuno imaging",
      "MTT",
      "https://doi.org/10.1101/2021.03.30.437757"
    ],
    [
      "MU-UNMC-1 a",
      "-",
      "0.67,1.16",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "human bronchial epithelial cell line (UNCN1T),",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "MU-UNMC-2",
      "-",
      "1.72, 0.89 ",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "human bronchial epithelial cell line (UNCN1T),",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "MU-UNMC-1 a",
      "-",
      "5.35, 2.94",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "Vero- STAT1 knockout cells",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "MU-UNMC-2",
      "-",
      "1.63, 0.54",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WI1/2020 (",
      "Vero- STAT1 knockout cells",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.02.438204"
    ],
    [
      "Amiloride",
      "-",
      "11.28",
      "-",
      ">100",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "Dimethyl amiloride",
      "-",
      "1.716",
      "-",
      ">100",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52282",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "Ethyl isopropyl amiloride",
      "-",
      "0.714",
      "-",
      "60.57",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52283",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "Hexamethylene amiloride",
      "-",
      "0.653",
      "-",
      "13.86",
      "SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52284",
      "Vero E6",
      "-",
      "Immunofluorescence",
      "-",
      "https://doi.org/10.1101/2021.04.06.438579"
    ],
    [
      "PF-03882845",
      "-",
      "10.97",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Inauhzin",
      "-",
      "12.96",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Inauhzin EC50+Remdesivir",
      "-",
      "11.25",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Trifluperidol",
      "-",
      "14.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Lomeguatrib",
      "-",
      "59.84",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "PF-03882845 EC50+Remdesivir",
      "-",
      "4.79",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Trifluperidol EC50+Remdesivir",
      "-",
      "5.05",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Lomeguatrib EC50+Remdesivir",
      "-",
      "44.14",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438810"
    ],
    [
      "Patulin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438812"
    ],
    [
      "Aurintricarboxylic acid",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438812"
    ],
    [
      "NSC95397",
      "-",
      "-",
      "not active ",
      "<10",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438811"
    ],
    [
      "Dihydrotanshinone I",
      "-",
      "8.148",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Ro 08-2750",
      "-",
      "20",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Cryptotanshinone",
      "-",
      ">200",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Tanshinone IIA",
      "-",
      ">200",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "GRL-0617",
      "-",
      "32.6",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Dihydrotanshinone I+Remdesivir",
      "-",
      "5.348",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Ro 08-2750+Remdesivir",
      "-",
      "22.7",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Beta-Lapachone",
      "-",
      "-",
      "toxic",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Cdk4 Inhibitor III",
      "-",
      "-",
      "toxic",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438804"
    ],
    [
      "Suramin",
      "-",
      "9.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "FPA-124",
      "-",
      "14",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "SSYA10-001",
      "-",
      "80.5",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "Myricetin",
      "-",
      "31.6",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "Suramin + Remdesivir",
      "-",
      "10.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "FPA-124 + Remdesivir",
      "-",
      "16.2",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "SSYA10-001 + Remdesivir",
      "-",
      "63.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "Myricetin + Remdesivir",
      "-",
      "24.4",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438808"
    ],
    [
      "GSK-650394 + 0.5 \u00b5M Remdesivir",
      "-",
      "8.5",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "C646 BH3I-1 + 0.5 \u00b5M Remdesivir",
      "-",
      "32",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "BH3I-1 + 0.5 \u00b5M Remdesivir ",
      "-",
      "61",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "MDK-83190  + 0.5 \u00b5M Remdesivir",
      "-",
      "77",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "Cefsulodin  + 0.5 \u00b5M Remdesivir",
      "-",
      "120",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "GSK-650394",
      "-",
      "7.6",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "C646",
      "-",
      "19",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "BH3I-1",
      "-",
      "77",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "MDK-83190",
      "-",
      "81",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "Cefsulodin",
      "-",
      "108",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438807"
    ],
    [
      "Calpain Inhibitor I",
      "-",
      "0.28",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "Z-VAD-FMK",
      "-",
      "138",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "Z-AVLD-FMK",
      "-",
      "66",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "Calpain Inhibitor I + 0.5 \u00b5M Remdesivir",
      "-",
      "0.34",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "Z-VAD-FMK + 0.5 \u00b5M Remdesivir",
      "-",
      "92.9",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "Z-AVLD-FMK + 0.5 \u00b5M Remdesivir",
      "-",
      "65.2",
      "-",
      "-",
      "SARS-CoV2",
      "VERO E6",
      "-",
      "Immunofluorescence imaging",
      "DRAQ7 staining",
      "https://doi.org/10.1101/2021.04.07.438806"
    ],
    [
      "Camostat",
      "-",
      ">5",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Nafamostat",
      "-",
      ">5",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Aprotinin",
      "-",
      ">50",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Bromhexine hydrochloride",
      "-",
      "20-21",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Niclosamide",
      "-",
      "0.11-0.20",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Ciclesonide",
      "-",
      "5.22-6.15",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Remdesivir",
      "-",
      "4.48-7.70",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "EIDD-2801",
      "-",
      "24.4->50",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "EIDD-1931",
      "-",
      "1.34-1.70",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Vero E6",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Camostat",
      "-",
      "0.10-0.17",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Nafamostat",
      "-",
      "0.02",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Aprotinin",
      "-",
      "0.7-1.04",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Bromhexine hydrochloride",
      "-",
      "12.2-29.44",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Niclosamide",
      "-",
      "1.21-1.59",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Ciclesonide",
      "-",
      "5.54-8.98",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "Remdesivir",
      "-",
      "0.42-0.73",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "EIDD-2801",
      "-",
      "1.7-3.4",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "EIDD-1931",
      "-",
      "0.24-0.35",
      "-",
      "-",
      "SARS-CoV2 (hCoV-19/Korea/KCDC03/2020), B.1.1.7 (hCoV148 19/Korea/KDCA51463/2021), B.1.351 (hCoV-19/Korea/KDCA55905/2021)",
      "Calu\u20103",
      "-",
      "Immunofluorescence imaging",
      "Hoechst 33342 staining",
      "https://doi.org/10.1101/2021.04.06.438540"
    ],
    [
      "7-hydroxystaurosporine",
      "-",
      "<5.09",
      "-",
      "-",
      "SARS-CoV2 ",
      "Caco2-ACE2",
      "-",
      "Immunofluorescence imaging",
      "-",
      "https://doi.org/10.1101/2021.04.15.440004"
    ],
    [
      "Bafetinib",
      "-",
      "<1.22",
      "-",
      "-",
      "SARS-CoV2 ",
      "Caco2-ACE2",
      "-",
      "Immunofluorescence imaging",
      "-",
      "https://doi.org/10.1101/2021.04.15.440004"
    ],
    [
      "Bafetinib+7-hydroxystaurosporine",
      "-",
      "0.65",
      "-",
      "-",
      "SARS-CoV2 ",
      "Caco2-ACE3",
      "-",
      "Immunofluorescence imaging",
      "-",
      "https://doi.org/10.1101/2021.04.15.440004"
    ],
    [
      "Celastrol",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 ( Brazil/SPBR-02/2020 strain)",
      "Vero CCL-81, Vero CCL-81-ACE2,  Caco-2, and  Calu-3",
      "-",
      "RT-PCR",
      "Alamar Blue",
      "https://doi.org/10.1101/2021.04.20.439992"
    ],
    [
      "Narasin ",
      "-",
      "0.07",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "K-strophanthidin  ",
      "-",
      "0.75",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Ouabain  ",
      "-",
      "0.045",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "VE-822 ",
      "-",
      "1.33",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Nanchangmycin  ",
      "-",
      "0.15",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Obatoclax  ",
      "-",
      "0.048",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "BET-BAY-002  ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "BMS-986158 ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "CPI-0610",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Mivebresib",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Calpeptin ",
      "-",
      "2",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Proscillaridin ",
      "-",
      "0.001",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "VBY-825 ",
      "-",
      "1.8",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Talniflumate ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Pralatrexate ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "BAY-2402234 ",
      "-",
      "0.006",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Sangivamycin ",
      "-",
      "0.045",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Anisomycin ",
      "-",
      "0.049",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Eliglustat",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "A-485 ",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "BIX-01294 ",
      "-",
      "0.82",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "AT13387 ",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Ganetespib",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "NVP-HSP990",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "SNX-2112",
      "-",
      " >4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Apilimod (STA5326) ",
      "-",
      "0.1",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Omipalisib (GSK2126458) ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Deslanoside ",
      "-",
      "0.165",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Mepacrine  ",
      "-",
      "1.33",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "APY0201 ",
      "-",
      "0.3",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "MG-132 ",
      "-",
      "0.15",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Bruceantin ",
      "-",
      "0.11",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Emetine ",
      "-",
      "0.125",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Harringtonine ",
      "-",
      "0.12",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Homoharringtonine ",
      "-",
      "0.43",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Tioguanine  ",
      "-",
      "1.2",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Niclosamide  ",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Bafilomycin A1 ",
      "-",
      "0.12",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "GSK-2660614",
      "-",
      ">4",
      "-",
      "-",
      "SARS-CoV-2 strain USAWA1/2020",
      "Vero E6",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.20.440626"
    ],
    [
      "Enzalutamide",
      "-",
      "-",
      "not active",
      "-",
      "SARSCoV-2/human/Liverpool/REMRQ0001/2020",
      "differentiated primary human airway",
      "-",
      "RT-qPCR",
      "LDH",
      "https://doi.org/10.1101/2021.04.23.440619"
    ],
    [
      "Camostat mesylate",
      "-",
      "-",
      "active",
      "-",
      "SARSCoV-2/human/Liverpool/REMRQ0001/2020",
      "differentiated primary human airway",
      "-",
      "RT-qPCR",
      "LDH",
      "https://doi.org/10.1101/2021.04.23.440619"
    ],
    [
      "Niclosamide",
      "-",
      "0.06",
      "-",
      "-",
      "SARS-CoV-2,Wuhan D614",
      "VeroE6 TMPRSS2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "Niclosamide",
      "-",
      "0.13",
      "-",
      "-",
      "SARS-CoV-2, BavPat D614G ",
      "VeroE6 TMPRSS2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "Niclosamide",
      "-",
      "0.08",
      "-",
      "-",
      "SARS-CoV-2, UK B.1.1.7",
      "VeroE6 TMPRSS2",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "Niclosamide",
      "-",
      "0.07",
      "-",
      "-",
      "SARS-CoV-2,SA 96 B.1.351",
      "VeroE6 TMPRSS3",
      "-",
      "RT-qPCR",
      "-",
      "https://doi.org/10.1101/2021.04.26.441457"
    ],
    [
      "Iota-carrageenan",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2, provided by Dr. Sandra Gallegos (National University of\n79 C\u00f3rdoba, Argentina)",
      "Calu-3",
      "-",
      "Plaque assays",
      "-",
      "https://doi.org/10.1101/2021.04.27.441512"
    ],
    [
      "Remdesivir",
      "-",
      "2.5",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "GC-376",
      "-",
      "3.9",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Hopeaphenol",
      "-",
      "10.2",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Vatalbinoside A",
      "-",
      "13.8",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Vaticanol B",
      "-",
      "37",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 ",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Resveratrol",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2, USA-WA1/2020 virus",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "resazurin staining",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Hopeaphenol",
      "-",
      "14.8",
      "-",
      "-",
      "B.1.1.7 (England/204820464/2020; \u201cUK variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Hopeaphenol",
      "-",
      "2.3",
      "-",
      "-",
      "B.1.351 (KRISP-K005325/2020; \u201cSouth Africa variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Remdesivir",
      "-",
      "1.5",
      "-",
      "-",
      "B.1.1.7 (England/204820464/2020; \u201cUK variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Remdesivir",
      "-",
      "1.4",
      "-",
      "-",
      "B.1.351 (KRISP-K005325/2020; \u201cSouth Africa variant\u201d)",
      "Vero-E6",
      "-",
      "Cytopathic effect",
      "-",
      "https://doi.org/10.1101/2021.04.29.442010;"
    ],
    [
      "Camostat mesylate",
      "-",
      "0.0106",
      "-",
      "-",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0130 ",
      "-",
      "0.0301",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0438",
      "-",
      "0.0357",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0386",
      "-",
      "0.0023",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0385",
      "-",
      "0.0028",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0385(OH)",
      "-",
      ">1",
      "-",
      "-",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0385",
      "-",
      "0.0034",
      "-",
      "-",
      "B.1.1.7",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0385",
      "-",
      "0.0131",
      "-",
      "-",
      "B.1.351",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "N-0385",
      "-",
      "0.0052",
      "-",
      ">1000",
      "SARS-CoV-2 (SARS438 COV-2/Canada/VIDO-01/2020)",
      "Calu-3",
      "-",
      "Immunofluorescence imaging",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.03.442520"
    ],
    [
      "Cyclo(DLK)R-kbt",
      "-",
      "0.66",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "Ac-IQFR-kbt",
      "-",
      "0.102",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "Ac-QFR-kbt",
      "-",
      "0.105",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "Ac-PQFR-kbt",
      "-",
      "0.052",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "Ac-GQFR-kbt",
      "-",
      "0.074",
      "-",
      "-",
      "wt SARS-CoV-2",
      "Calu-3",
      "-",
      "Cell Titer-Glo",
      "Cell Titer-Glo",
      "https://doi.org/10.1101/2021.05.06.442935"
    ],
    [
      "N-butyl deoxynojirimycin",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (USA-WA1/2020 strain)",
      " A549ACE2",
      "-",
      "imaging",
      "-",
      "https://doi.org/10.1101/2021.05.14.444190"
    ],
    [
      "Ureido-N-hexyl deoxynojirimycine",
      "-",
      "-",
      "active",
      "-",
      "SARS-CoV-2 (USA-WA1/2020 strain)",
      " A549ACE2",
      "-",
      "imaging",
      "-",
      "https://doi.org/10.1101/2021.05.14.444190"
    ],
    [
      "Allicin",
      "diallyl thiosulfinate",
      "-",
      "active",
      "-",
      "SARS-CoV-2 Munich isolate (CSpecVir985)",
      "Calu-3, Vero E6",
      "-",
      "RT-qPCR, microscopy imaging",
      "CellTiter-Glo",
      "https://doi.org/10.1101/2021.05.15.444275"
    ],
    [
      "Ivermectin",
      "-",
      "1.9",
      "-",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "Moxidectin",
      "-",
      "4.5",
      "-",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Vero E6",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "Ivermectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Calu-3",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "Moxidectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "Calu-3",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "Ivermectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "primary human bronchial epithelial cells (PBECs)",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "Moxidectin",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV-2 strain /NL/2020 (European Virus archive global (EVAg), 010V-03903)",
      "primary human bronchial epithelial cells (PBECs)",
      "-",
      "Plaque assay",
      "MTS, LDH",
      "https://doi.org/10.1101/2021.05.17.444467"
    ],
    [
      "Probenecid",
      "-",
      "0.75",
      "-",
      "-",
      "SARS-CoV-2 isolate nCoV-WA1-2020",
      "Vero E6",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.05.21.445119"
    ],
    [
      "Probenecid",
      "-",
      "0.0013",
      "-",
      "-",
      "SARS-CoV-2 isolate nCoV-WA1-2020",
      "normal human bronchoepithelial",
      "-",
      "Plaque assay",
      "-",
      "https://doi.org/10.1101/2021.05.21.445119"
    ],
    [
      "Defensin HNP1",
      "-",
      "10.3",
      "-",
      "-",
      "SARS-CoV-2, USA-WA1/2020 ",
      "Vero E6",
      "-",
      "Flow cytometry",
      "-",
      "https://doi.org/10.1101/2021.05.27.445985"
    ],
    [
      "Molnupiravir",
      "EIDD-2801 / MK-4482 / MedChemExpress HY-135853",
      "232.2",
      "active",
      "-",
      "Omicron variant [B.1.1.529; BA.1]-patient isolate [hCoV-19/Czech_Republic/KNL_2021-110119140/2021; GISAID \naccession code: EPI_ISL_6862005]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "B+A1075eta-d-N4-hydroxycytidine",
      "molnupiravir derivate / MedChemExpress HY-125033",
      "70.9",
      "active",
      "-",
      "Omicron variant [B.1.1.529; BA.1]-patient isolate [hCoV-19/Czech_Republic/KNL_2021-110119140/2021; GISAID \naccession code: EPI_ISL_6862005]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Nirmatrelvi+ritonavir",
      "Paxlovid / PF-07321332 / MedChemExpress HY-138687",
      "0.0094",
      "active",
      "-",
      "Omicron variant [B.1.1.529; BA.1]-patient isolate [hCoV-19/Czech_Republic/KNL_2021-110119140/2021; GISAID \naccession code: EPI_ISL_6862005]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Acriflavine",
      "A8126",
      "0.0195",
      "active",
      "-",
      "Omicron variant [B.1.1.529; BA.1]-patient isolate [hCoV-19/Czech_Republic/KNL_2021-110119140/2021; GISAID \naccession code: EPI_ISL_6862005]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Remdesivir",
      "Veklury / GS-441524",
      "0.2932",
      "active",
      "-",
      "Omicron variant [B.1.1.529; BA.1]-patient isolate [hCoV-19/Czech_Republic/KNL_2021-110119140/2021; GISAID \naccession code: EPI_ISL_6862005]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Bemnifosbuvir hemisulfate",
      "AT-527 / MedChemExpress HY-137958",
      " - ",
      "not active (prodrug to active metabolite impairment?)",
      "-",
      "Omicron variant [B.1.1.529; BA.1]-patient isolate [hCoV-19/Czech_Republic/KNL_2021-110119140/2021; GISAID \naccession code: EPI_ISL_6862005]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Molnupiravir",
      "EIDD-2801 / MK-4482 / MedChemExpress HY-135853",
      "1299",
      "active",
      "-",
      "Delta variant (B.1.617.2) - patient isolate [hCoV-19/Czech Republic/NRL_7102/2021; GISAID accession code: EPI_ISL_2357738]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Beta-d-N4-hydroxycytidine",
      "molnupiravir derivate / MedChemExpress HY-125033",
      "169.6",
      "active",
      "-",
      "Delta variant (B.1.617.2) - patient isolate [hCoV-19/Czech Republic/NRL_7102/2021; GISAID accession code: EPI_ISL_2357738]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Nirmatrelvi+ritonavir",
      "Paxlovid / PF-07321332 / MedChemExpress HY-138687",
      "0.0079",
      "active",
      "-",
      "Delta variant (B.1.617.2) - patient isolate [hCoV-19/Czech Republic/NRL_7102/2021; GISAID accession code: EPI_ISL_2357738]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Acriflavine",
      "A8126",
      "0.0535",
      "active",
      "-",
      "Delta variant (B.1.617.2) - patient isolate [hCoV-19/Czech Republic/NRL_7102/2021; GISAID accession code: EPI_ISL_2357738]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Remdesivir",
      "Veklury / GS-441524",
      "0.5505",
      "active",
      "-",
      "Delta variant (B.1.617.2) - patient isolate [hCoV-19/Czech Republic/NRL_7102/2021; GISAID accession code: EPI_ISL_2357738]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Bemnifosbuvir hemisulfate",
      "AT-527 / MedChemExpress HY-137958",
      " - ",
      "not active (prodrug to active metabolite impairment?)",
      "-",
      "Delta variant (B.1.617.2) - patient isolate [hCoV-19/Czech Republic/NRL_7102/2021; GISAID accession code: EPI_ISL_2357738]",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Molnupiravir",
      "EIDD-2801 / MK-4482 / MedChemExpress HY-135853",
      "108.9",
      "active",
      "-",
      "SARS-CoV2 (B.1.13) - patient isolate (hCoV-19/Poland/PL_P7/2020; GISAID accession code: EPI_ISL_428930)",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Beta-d-N4-hydroxycytidine",
      "molnupiravir derivate / MedChemExpress HY-125033",
      "375.7",
      "active",
      "-",
      "SARS-CoV2 (B.1.13) - patient isolate (hCoV-19/Poland/PL_P7/2020; GISAID accession code: EPI_ISL_428930)",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Nirmatrelvi+ritonavir",
      "Paxlovid / PF-07321332 / MedChemExpress HY-138687",
      "0.0105",
      "active",
      "-",
      "SARS-CoV2 (B.1.13) - patient isolate (hCoV-19/Poland/PL_P7/2020; GISAID accession code: EPI_ISL_428930)",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Acriflavine",
      "A8126",
      "0.1049",
      "active",
      "-",
      "SARS-CoV2 (B.1.13) - patient isolate (hCoV-19/Poland/PL_P7/2020; GISAID accession code: EPI_ISL_428930)",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Remdesivir",
      "Veklury / GS-441524",
      "0.3932",
      "active",
      "-",
      "SARS-CoV2 (B.1.13) - patient isolate (hCoV-19/Poland/PL_P7/2020; GISAID accession code: EPI_ISL_428930)",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Bemnifosbuvir hemisulfate",
      "AT-527 / MedChemExpress HY-137958",
      " - ",
      "not active (prodrug to active metabolite impairment?)",
      "-",
      "SARS-CoV2 (B.1.13) - patient isolate (hCoV-19/Poland/PL_P7/2020; GISAID accession code: EPI_ISL_428930)",
      "A549ACE2+TMPRSS2+ cells",
      "1120pfu/ml",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.21.473268"
    ],
    [
      "Boceprevir (key sites for derivates changes: a-ketoamide warhead,  P1- b-cyclobutylalanyl moiety, P2 dimethylcyclopropylproline, P3-tert-butylglycine, P4 N-terminal tert-butylcarbamide)",
      "-",
      "-",
      "-",
      "-",
      "-",
      "-",
      "nan",
      "flow cytometry",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI29 - boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "CPE - transfection of Mpro (lentiviral construct - pLVX-MPro-eGFP-2) into human cells  leads to direct cell cytotoxicity; inhibitor prevents cell death leading to increase in YFP signal - internal method; doi: https://doi.org/10.1101/2021.06.08.447613; not peer reviewed",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI30-boceprevir derivate",
      "-",
      "> 5uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI31-boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI32-boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI33-boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI34-boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI35-boceprevir derivate",
      "-",
      "> 5uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI36-boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI37-boceprevir derivate (P2- (S)-5-\nazaspiro[2,4]heptane-6-carboxylic acid)",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI38-boceprevir derivate (P2-neo-pentylglycine)",
      "-",
      "> 5uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI39-boceprevir derivate",
      "-",
      "> 10uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI40-boceprevir derivate (P4 N-terminal amide cap)",
      "-",
      "7.4 \u00b1 0.9uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI41-boceprevir derivate (P4 N-terminal amide cap)",
      "-",
      "7.7 \u00b1 1.5uM",
      "low potency",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI42-boceprevir derivate (P4 N-terminal amide cap)",
      "-",
      "2.6 \u00b1 0.5uM",
      "-",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI43-boceprevir derivate (P4 N-terminal carbamate)",
      "-",
      "0.37 \u00b1 0.04uM",
      "-",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI44-boceprevir derivate (P4 N-terminal CBZ cap)",
      "-",
      "0.31 \u00b1 0.03uM",
      "-",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI45-boceprevir derivate (P4 N-terminal carbamide cap)",
      "-",
      "0.74 \u00b1 0.11uM",
      "-",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI46-boceprevir derivate ",
      "-",
      "0.14 \u00b1 0.02uM",
      "-",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI47-boceprevir derivate (a P4 N-terminal amide)",
      "-",
      "> 10uM",
      "-",
      "-",
      "no infection",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "PF-07321332-boceprevir derivate (a P4 N-terminal amide)",
      "-",
      "3.4 \u00b1 0.8uM",
      "-",
      "-",
      "-",
      "human 293T cells expressing MPro-eGFP",
      "nan",
      "flow cytometry",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI43-boceprevir derivate (P4 N-terminal carbamate)",
      "-",
      "0.61uM",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI44-boceprevir derivate (P4 N-terminal CBZ cap)",
      "-",
      "2.94uM",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI46-boceprevir derivate (P4 N-terminal carbamide cap)",
      "-",
      "1.08uM",
      "-",
      "-",
      "USA-WA1/2020",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI43-boceprevir derivate (P4 N-terminal carbamate)",
      "-",
      "0.36uM",
      "-",
      "-",
      "SARS-CoV2 (Beta variant)",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI44-boceprevir derivate (P4 N-terminal CBZ cap)",
      "-",
      "0.86uM",
      "-",
      "-",
      "SARS-CoV2 (Beta variant)",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI46-boceprevir derivate (P4 N-terminal carbamide cap)",
      "-",
      "2.28uM",
      "-",
      "-",
      "SARS-CoV2 (Beta variant)",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI43-boceprevir derivate (P4 N-terminal carbamate)",
      "-",
      "1.0uM",
      "-",
      "-",
      "SARS-CoV2 (Delta variant)",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI44-boceprevir derivate (P4 N-terminal CBZ cap)",
      "-",
      "1.04uM",
      "-",
      "-",
      "SARS-CoV2 (Delta variant)",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "MPI46-boceprevir derivate (P4 N-terminal carbamide cap)",
      "-",
      "0.75uM",
      "-",
      "-",
      "SARS-CoV2 (Delta variant)",
      "Vero E6",
      "not given",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.18.473330"
    ],
    [
      "Vandetanib",
      "-",
      "2uM",
      "-",
      "-",
      "-",
      "Caco-2",
      "-",
      "-",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Vandetanib",
      "-",
      "0.79uM",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-hACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Entrectinib",
      "-",
      "1.97uM",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Remdesivir (pos.ctr)",
      "-",
      "0.11uM",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Entrectinib",
      "-",
      "-",
      "toxic",
      "-",
      "SARS-CoV2-isolate USA WA1/2020",
      "Caco-2",
      "not known",
      "Nano-Glo Luciferase assay (viral growth",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Entrectinib",
      "-",
      "3.6uM",
      "toxic",
      "3.6uM",
      "SARS-CoV2-isolate USA WA1/2021",
      "Calu-3",
      "0.5",
      "immunostaining",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Remdesivir (pos.ctr)",
      "-",
      "0.09uM",
      "active (pos. ctr)",
      ">10uM",
      "SARS-CoV2-isolate USA WA1/2021",
      "Calu-3",
      "0.5",
      "immunostaining",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Crizotinib",
      "-",
      "-",
      "toxic",
      "-",
      "SARS-CoV2-isolate USA WA1/2022",
      "Calu-3",
      "0.5",
      "immunostaining",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Dasatinib",
      "-",
      "not given",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth)",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Afatinib",
      "-",
      "not given",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth)",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Brigatinib",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth)",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Ceritinib",
      "-",
      "not given",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth)",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Cerdulatinib",
      "-",
      "-",
      "not active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth)",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Gefitinib",
      "-",
      "not given",
      "active",
      "-",
      "SARS-CoV2-nLuc",
      "A549-ACE2 cells",
      "0.02",
      "Nano-Glo Luciferase assay (viral growth)",
      "CytoTox-Glo Cytotoxicity (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.16.472155"
    ],
    [
      "Nitazoxanide",
      "-",
      "3.19uM",
      "active",
      ">60uM",
      "SARS-CoV2 strain BavPat1",
      "Vero E6 (ACE2/TMPRSS2) ",
      "-",
      "qRT-PCR",
      "CellTiter Blue (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.17.473113"
    ],
    [
      "Nitazoxanide",
      "-",
      "0.58uM",
      "active",
      "9.15uM",
      "SARS-CoV2 strain BavPat1",
      "Caco-2 cells  (ACE2/TMPRSS2) ",
      "-",
      "qRT-PCR",
      "CellTiter Blue (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.17.473113"
    ],
    [
      "Tizoxanide (active circulating metabolite)",
      "-",
      "7.48uM",
      "active",
      ">60uM",
      "SARS-CoV2 strain BavPat1",
      "Vero E6 (ACE2/TMPRSS2) ",
      "-",
      "qRT-PCR",
      "CellTiter Blue (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.12.17.473113"
    ],
    [
      "Tannic acid",
      "-",
      "49.71uM ",
      "active/toxic",
      ">30uM",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "293T expressing ACE2 (with fluorescent marker)",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "Anthraquinone",
      "TS-1276",
      "55.9uM",
      "not active?",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "293T expressing ACE2 (with fluorescent marker)",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "9-Methoxycanthin-6-one",
      "TS-984",
      "36.21uM",
      "possibly active",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "293T expressing ACE2 (with fluorescent marker)",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "nafamostat mesylate",
      "-",
      "11.34uM",
      "positive control",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "293T expressing ACE2 (with fluorescent marker)",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "Tannic acid",
      "-",
      "not given",
      "inhibits entry of SARS-CoV2",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "Capan2 overexpressing ACE2",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "Anthraquinone",
      "-",
      "not given",
      "inhibits entry of SARS-CoV2",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "Capan2 overexpressing ACE2",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "9-Methoxycanthin-6-one",
      "-",
      "not given",
      "inhibits entry of SARS-CoV2",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "Capan2 overexpressing ACE2 ",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "nafamostat mesylate",
      "-",
      "not given",
      "inhibits entry of SARS-CoV2",
      "-",
      "SARS-CoV-2_S (D614G)-pseudotyped lentivirus",
      "Capan2 overexpressing ACE2",
      "not given",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.14.472545"
    ],
    [
      "Echinaforce",
      "Echinacea purpurea extract",
      "3.62 +/- 2.09 \u00b5g/ml",
      "inhibits entry of SARS-CoV2",
      "-",
      "Lentiviral psuedotyped virus transfected with D614 (SARS-CoV2 spike); ",
      "Vero E6",
      "250pfu/well",
      "plaque assay",
      "CPE  for 72 hours followed by staining with 0.5% crystal violet, 20% methanol in dH2O",
      "doi:\u00a0https://doi.org/10.1101/2021.12.12.472255"
    ],
    [
      "Echinaforce",
      "Echinacea purpurea extract",
      "5.37 - 12.03 ",
      ">25ug/ml for complete prevention of viral propagation",
      "-",
      "SARS-CoV2 VOCs: B.1.1.7 (alpha), \nB1.351 (beta) and P.1 (gamma), Pleschka, University Giessen, Germany), B.1.1.7 (alpha), B1.617.2 (delta), AV.1 (Scotland) \nand B1.525 (eta) (Pariani, University Milano, Italy) OC43 (Vimalanathan, University British Columbia, Canada)",
      "Vero E7",
      "250pfu/well",
      "plaque assay",
      "CPE  for 72 hours followed by staining with 0.5% crystal violet, 20% methanol in dH2O",
      "doi:\u00a0https://doi.org/10.1101/2021.12.12.472255"
    ],
    [
      "Echinaforce",
      "Echinacea purpurea extract (medicinal plant)",
      "-",
      "MIC100 = lowest concentration for inhibition = 1ug/ml",
      "-",
      "SARS-CoV2 variant P.1, B.1.351 and B.1.1.7",
      "Vero E8",
      "250pfu/well",
      "plaque assay",
      "CPE  for 72 hours followed by staining with 0.5% crystal violet, 20% methanol in dH2O",
      "doi:\u00a0https://doi.org/10.1101/2021.12.12.472255"
    ],
    [
      "Echinaforce",
      "Echinacea purpurea extract (medicinal plant)",
      "-",
      "MIC100 = 20ug/ml",
      "-",
      "SARS-CoV2",
      "human nasal epithelium",
      "1",
      "plaque assay ",
      " immunofluorescence staining with mAB against TMPRSS-2 - ",
      "doi:\u00a0https://doi.org/10.1101/2021.12.12.472255"
    ],
    [
      "PAV-431",
      "-",
      "100nM",
      "-",
      "-",
      "SARS-CoV2 delta",
      "Vero E6",
      "0.01 for 1 hour",
      "plaque assay",
      "CPE - crystal violet staining of plaques",
      "doi:\u00a0https://doi.org/10.1101/2021.01.17.426875"
    ],
    [
      "PAV-617",
      "-",
      "100nM",
      "-",
      "-",
      "SARS-CoV2 delta",
      "Vero E6",
      "0.01 for 1 hour",
      "plaque assay",
      "CPE - crystal violet staining of plaques",
      "doi:\u00a0https://doi.org/10.1101/2021.01.17.426875"
    ],
    [
      "PAV-431",
      "-",
      "-",
      "-",
      "-",
      "SARS-CoV2-delta SL102 (EPI_ISL_4471559)",
      "Calu-3",
      "0.05",
      "RNA qPCR",
      "CPE - CellTiter-Glo (Promega)",
      "doi:\u00a0https://doi.org/10.1101/2021.01.17.426875"
    ],
    [
      " 2-Deoxy-D-glucose (2-DG)",
      "-",
      "0.75mM",
      "active",
      "-",
      "SARS-CoV2-patient isolate -B1.1 variant (INMAS/nCoV/8415)",
      "Vero E6",
      "0.3",
      "RT-PCR",
      "CPE\nproliferation efficiency with CFSE staining (flow cutometry)",
      "DOI:\u00a010.1016/j.lfs.2022.120411"
    ],
    [
      "2-Deoxy-D-glucose (2-DG)",
      "-",
      "1mM",
      "-",
      "-",
      "SARS-CoV-2 (B.6 variant -  hCoV-19/India/TG-CCMB-O2-P1/2020)",
      "-",
      "0.3",
      "RT-PCR",
      "CPE\nproliferation efficiency with CFSE staining (flow cutometry)",
      "DOI:\u00a010.1016/j.lfs.2022.120411"
    ],
    [
      "NCG00411718-01",
      "-",
      "0.95uM",
      "-",
      "nan",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00411727-01",
      "-",
      "4.15uM",
      "-",
      "nan",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00411588-01",
      "-",
      "5.36uM",
      "-",
      "nan",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00119962-01",
      "-",
      "5.86uM",
      "-",
      "nan",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00411611-01",
      "-",
      "5.86uM",
      "-",
      "18.55uM",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00411733-01",
      "-",
      "6.75uM",
      "-",
      "26.89uM",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00411138-01",
      "-",
      "7.58uM",
      "-",
      "23.97uM",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00159478-04",
      "-",
      "4.13uM",
      "-",
      "16.53uM",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00411705-01",
      "-",
      "4.66uM",
      "-",
      "16.53uM",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "NCGC00115755-02",
      "-",
      "8.28uM",
      "-",
      "10.43uM",
      "SARS-CoV2 pseudotyped particles",
      "HEK293T-ACE2-GFP cells",
      "-",
      "CPE",
      "Bright-Glo luciferase",
      "doi:\u00a0https://doi.org/10.1101/2021.12.08.471787"
    ],
    [
      "Petasite hybridus CO2 extract",
      "Ze339",
      "0.1ug/ml",
      "-",
      ">20ug/ml",
      "SARS-CoV2 Wuhan strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "petasin",
      "-",
      "10.79uM",
      "-",
      ">63uM",
      "SARS-CoV2 Wuhan strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "isopetasin",
      "-",
      "0.37uM",
      "-",
      ">63uM",
      "SARS-CoV2 Wuhan strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "neopetasin",
      "-",
      "1.26uM",
      "-",
      ">63uM",
      "SARS-CoV2 Wuhan strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "Remdesivir (pos.ctr)",
      "-",
      "2.37uM",
      "-",
      ">50uM",
      "SARS-CoV2 Wuhan strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "Petasite hybridus CO2 extract",
      "Ze339",
      "0.4ug/ml",
      "-",
      "-",
      "SARS-CoV2 Delta strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "petasin",
      "-",
      "nan",
      "-",
      "-",
      "SARS-CoV2 Delta strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "isopetasin",
      "-",
      "0.88uM",
      "-",
      "-",
      "SARS-CoV2 Delta strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "neopetasin",
      "-",
      "nan",
      "-",
      "-",
      "SARS-CoV2 Delta strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "Remdesivir (pos.ctr)",
      "-",
      "1.53uM",
      "-",
      "-",
      "SARS-CoV2 Delta strain",
      "Vero E6",
      "100pfu/well",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/v14010106"
    ],
    [
      "EACC",
      "-",
      ">100uM",
      "not active",
      "35.29uM",
      "SARS-CoV2",
      "Calu-3",
      "very little information regarding infection assay",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.02.471030"
    ],
    [
      "KY-226",
      "-",
      "25.0uM",
      "-",
      "41.3uM",
      "SARS-CoV2",
      "Calu-3",
      "-",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.02.471030"
    ],
    [
      "tropifexor",
      "-",
      "4.03uM",
      "active",
      "28.1",
      "SARS-CoV2",
      "Calu-3",
      "-",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.02.471030"
    ],
    [
      "GRL0617(pos ctr)",
      "-",
      "31.4uM",
      "-",
      ">40uM",
      "SARS-CoV2",
      "Calu-3",
      "-",
      "-",
      "immunofluorescence",
      "doi:\u00a0https://doi.org/10.1101/2021.12.02.471030"
    ],
    [
      "\u00df-D-N4-hydroxycytidine",
      "NHC/active metabolite of molnupiravir",
      "-",
      "-",
      "0.111uM",
      "SARS-CoV2 - Liverpool/REMRQ0001/2020 (B lineage)",
      "ACE-2 A549 cells (3-10 passage)",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.11.23.469695"
    ],
    [
      "\u00df-D-N4-hydroxycytidine",
      "NHC/active metabolite of molnupiravir",
      "-",
      "-",
      "0.104uM",
      "SARS-CoV2 - Alpha (B.1.1.7) ",
      "ACE-2 A549 cells (3-10 passage)",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.11.23.469696"
    ],
    [
      "\u00df-D-N4-hydroxycytidine",
      "NHC/active metabolite of molnupiravir",
      "-",
      "-",
      "0.134uM",
      "SARS-CoV2 - Beta (B.1.351)",
      "ACE-2 A549 cells (3-10 passage)",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.11.23.469697"
    ],
    [
      "\u00df-D-N4-hydroxycytidine",
      "NHC/active metabolite of molnupiravir",
      "-",
      "-",
      "0.103uM",
      "SARS-CoV2 - Delta (B.1.617.2)",
      "ACE-2 A549 cells (3-10 passage)",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.11.23.469698"
    ],
    [
      "\u00df-D-N4-hydroxycytidine",
      "NHC/active metabolite of molnupiravir",
      "-",
      "-",
      "-",
      "SARS-CoV2 - Liverpool/REMRQ0001/2020 (B lineage)",
      "ACE-2 A549 cells (3-10 passage)",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.11.23.469699"
    ],
    [
      "Atazanavir",
      "-",
      "0.49uM",
      "active",
      "312uM",
      "SARS-CoV2 P1 lineage - patient isolate",
      "Calu-3",
      "0.1",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/ph15010021"
    ],
    [
      "Atazanavir",
      "-",
      "0.321uM",
      "active",
      "312uM",
      "SARS-CoV2 B1 lineage - patient isolate",
      "Calu-3",
      "0.1",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/ph15010021"
    ],
    [
      "Atazanavir",
      "-",
      "0.399uM",
      "active",
      "312uM",
      "SARS-CoV2 B1 lineage - patient isolate",
      "Calu-3",
      "0.001",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/ph15010021"
    ],
    [
      "Remdesivir",
      "-",
      "0.461uM",
      "active",
      "512uM",
      "SARS-CoV2 P1 lineage - patient isolate",
      "Calu-3",
      "0.1",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/ph15010021"
    ],
    [
      "Remdesivir",
      "-",
      "0.225uM",
      "active",
      "512uM",
      "SARS-CoV2 B1 lineage - patient isolate",
      "Calu-3",
      "0.1",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/ph15010021"
    ],
    [
      "Remdesivir",
      "-",
      "0.113uM",
      "active",
      "512uM",
      "SARS-CoV2 B1 lineage - patient isolate",
      "Calu-3",
      "0.001",
      "plaque assay",
      "CPE",
      "DOI:\u00a010.3390/ph15010021"
    ],
    [
      "4-(2- hydroxyethyl)phenol",
      "YRL",
      "1uM",
      "active",
      ">100uM",
      "SARS-CoV2  - P1 strain?",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.11.17.468943"
    ],
    [
      "4-hydroxybenzaldehyde",
      "HBA",
      "1uM",
      "active",
      ">100uM",
      "SARS-CoV2  - P1 strain?",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.11.17.468943"
    ],
    [
      "Methyl 3, 4- dihydroxybenzoate",
      "HE9",
      "0.13uM",
      "active",
      "10.37uM",
      "SARS-CoV2  - P1 strain?",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.11.17.468943"
    ],
    [
      "GRl-0617 (pos. ctrl)",
      "-",
      "0.82uM",
      "active",
      "-",
      "SARS-CoV2  - P1 strain?",
      "Vero E6",
      "0.01",
      "qRT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2021.11.17.468943"
    ],
    [
      "Metformin",
      "-",
      "2.9mM",
      "active",
      "-",
      "SARS-CoV2",
      "Caco2",
      "1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.11.18.469078"
    ],
    [
      "Clofoctol",
      "-",
      "12.41uM",
      "-",
      ">40uM",
      "SARS-CoV2 (HCoV-229E, B1-D614G, B1.1.7, B.1.351)",
      "Vero-81",
      "0.25",
      "RT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.06.30.450483"
    ],
    [
      "Clofoctol",
      "-",
      "13.51uM",
      "-",
      ">40uM",
      "SARS-CoV2",
      "Vero-81-TMPRSS2 cells",
      "0.25",
      "RT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.06.30.450483"
    ],
    [
      "Clofoctol",
      "-",
      "7.9uM",
      "-",
      "-",
      "SARS-CoV2",
      "Calu-3",
      "0.25",
      "RT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.06.30.450483"
    ],
    [
      "WR-1065",
      "-",
      "1.38mM",
      "active",
      "-",
      "SARS-2-S pseudovirus  - SARS-2-S_(rVSV-\u0394G)-Luciderase",
      "(293T-ACE2-TMRPRSS2 cells",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Cysteamine",
      "-",
      "0.99mM",
      "active",
      "-",
      "SARS-2-S pseudovirus  - SARS-2-S_(rVSV-\u0394G)-Luciderase",
      "(293T-ACE2-TMRPRSS2 cells",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Tiopronin",
      "-",
      "104.6mM",
      "not active",
      "-",
      "SARS-2-S pseudovirus  - SARS-2-S_(rVSV-\u0394G)-Luciderase",
      "(293T-ACE2-TMRPRSS2 cells",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Mesna",
      "-",
      "63.86mM",
      "not active",
      "-",
      "SARS-2-S pseudovirus  - SARS-2-S_(rVSV-\u0394G)-Luciderase",
      "(293T-ACE2-TMRPRSS2 cells",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Bucillamine",
      "-",
      "26.02mM",
      "not active",
      "-",
      "SARS-2-S pseudovirus  - SARS-2-S_(rVSV-\u0394G)-Luciderase",
      "(293T-ACE2-TMRPRSS2 cells",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Cysteamine",
      "-",
      "1.54mM",
      "active",
      "-",
      "SARS-CoV2",
      "Vero E6",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "WR-1065",
      "-",
      "0.65mM",
      "active",
      "-",
      "SARS-CoV3",
      "Vero E6",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Mesna",
      "-",
      "46.54mM",
      "not active",
      "-",
      "SARS-CoV4",
      "Vero E6",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Bucillamine",
      "-",
      "31.33mM",
      "not active",
      "-",
      "SARS-CoV5",
      "Vero E6",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.0 ",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Carbocysteine (neg ctr)",
      "-",
      "no effect",
      "no effect",
      "-",
      "SARS-CoV6",
      "Vero E6",
      "-",
      "plaque assay",
      "CPE - Cell Titer Glo 2.1",
      "doi:\u00a0https://doi.org/10.1101/2020.12.08.415505"
    ],
    [
      "Darapladib",
      "-",
      "0.8uM",
      "active",
      "17.4uM",
      "SARS2-NanoLuc reporter virus",
      "A549-hACE2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Genz-123346",
      "-",
      "1.6uM",
      "active",
      "99.7uM",
      "SARS2-NanoLuc reporter virus",
      "A549-hACE2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "JNJ-5207852",
      "-",
      "3.1uM",
      "active",
      ">100uM",
      "SARS2-NanoLuc reporter virus",
      "A549-hACE2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "GC376",
      "-",
      "0.65um",
      "active",
      ">50uM",
      "SARS2-NanoLuc reporter virus",
      "A549-hACE2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Remdesivir",
      "-",
      "<0.1uM",
      "active",
      ">50uM",
      "SARS2-NanoLuc reporter virus",
      "A549-hACE2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Darapladib",
      "-",
      "3.2uM",
      "active/narrow profile",
      "9.4uM",
      "SARS2-NanoLuc reporter virus",
      "Caco-2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Genz-123346",
      "-",
      "2uM",
      "active",
      "77.8uM",
      "SARS2-NanoLuc reporter virus",
      "Caco-2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "JNJ-5207852",
      "-",
      "1.0uM",
      "active",
      ">100uM",
      "SARS2-NanoLuc reporter virus",
      "Caco-2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "GC376",
      "-",
      "1.4uM",
      "active",
      ">50uM",
      "SARS2-NanoLuc reporter virus",
      "Caco-2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Remdesivir",
      "-",
      "<0.1uM",
      "active",
      ">50uM",
      "SARS2-NanoLuc reporter virus",
      "Caco-2",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Darapladib",
      "-",
      "0.9uM",
      "active",
      "7.6uM",
      "SARS2-NanoLuc reporter virus",
      "Calu-3 cells",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Genz-123346",
      "-",
      "11.1uM",
      "active/narrow profile",
      "33.3uM",
      "SARS2-NanoLuc reporter virus",
      "Calu-3 cells",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "JNJ-5207852",
      "-",
      "1.5uM",
      "active",
      ">100uM",
      "SARS2-NanoLuc reporter virus",
      "Calu-3 cells",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "GC376",
      "-",
      "0.2uM",
      "active",
      ">50uM",
      "SARS2-NanoLuc reporter virus",
      "Calu-3 cells",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Remdesivir",
      "-",
      "0.2uM",
      "active",
      ">50uM",
      "SARS2-NanoLuc reporter virus",
      "Calu-3 cells",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Darapladib",
      "-",
      "7.0uM",
      "active/narrow profile",
      "11.2uM",
      "BHK-21 replicon cells transduced with SARS-CoV2 RNA without M,S and E genes to minimise cell toxicity (SARS-CoV-2-Rep-NanoLuc-Neo-Nsp1K164A/H165A)",
      "-",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Genz-123346",
      "-",
      "4.0um",
      "active/narrow profile",
      "26.3uM",
      "BHK-21 replicon cells transduced with SARS-CoV2 RNA without M,S and E genes to minimise cell toxicity (SARS-CoV-2-Rep-NanoLuc-Neo-Nsp1K164A/H165A)",
      "-",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "JNJ-5207852",
      "-",
      "8.1uM",
      "active",
      "69.3uM",
      "BHK-21 replicon cells transduced with SARS-CoV2 RNA without M,S and E genes to minimise cell toxicity (SARS-CoV-2-Rep-NanoLuc-Neo-Nsp1K164A/H165A)",
      "-",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "GC376",
      "-",
      "0.9uM ",
      "active",
      "25uM",
      "BHK-21 replicon cells transduced with SARS-CoV2 RNA without M,S and E genes to minimise cell toxicity (SARS-CoV-2-Rep-NanoLuc-Neo-Nsp1K164A/H165A)",
      "-",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Remdesivir",
      "-",
      "1.6uM",
      "active",
      "70.7uM",
      "BHK-21 replicon cells transduced with SARS-CoV2 RNA without M,S and E genes to minimise cell toxicity (SARS-CoV-2-Rep-NanoLuc-Neo-Nsp1K164A/H165A)",
      "-",
      "0.05",
      "Nano-Glo Luciferase Assay System",
      "Cell-Titer Glo for cell viability assay",
      "doi:\u00a010.1128/jvi.02216-21"
    ],
    [
      "Elte N378 ",
      "-",
      ">30",
      "-",
      ">30",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6 with high ACE2 expression",
      "0.002",
      "CPE",
      "CellTiterGlo",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Elte N378 + Remdesivir (3uM)",
      "-",
      "19.6",
      "-",
      ">30",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6 with high ACE2 expression",
      "0.002",
      "CPE",
      "CellTiterGlo",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Remdesivir",
      "-",
      "7.31",
      "-",
      ">100",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6 with high ACE2 expression",
      "0.002",
      "CPE",
      "CellTiterGlo",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Elte N378+M128533 (1ug/ml)",
      "-",
      "<1.11",
      "-",
      ">30",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6 with high ACE2 expression",
      "0.002",
      "CPE",
      "CellTiterGlo",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "M128533 (ug/ml)",
      "-",
      "1.36",
      "-",
      ">100",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6 with high ACE2 expression",
      "0.002",
      "CPE",
      "CellTiterGlo",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "FK1706",
      "-",
      ">90",
      "not active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "FK1706+ Remdesivir (3uM)",
      "-",
      "<11.3",
      "synergistic",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Remdesivir (3uM); ",
      "-",
      ">3",
      "subtherapeutic",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Remdesivir",
      "-",
      "3.63",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "FK1706+M128533 (1ug/ml)",
      "-",
      "<11.3",
      "synergisitc effect",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "M128533 (1ug/ml)",
      "-",
      ">1",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "M128533",
      "-",
      "1.53",
      "-",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "FK1706+Molnupiravir (0.3uM)",
      "-",
      "28.7",
      "synergisitc effect",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Molnupiravir (single conc.)",
      "-",
      ">0.3",
      "not active",
      "-",
      "SARS-CoV-2 isolate USA-WA1/2020",
      "Vero E6",
      "0.001",
      "CPE",
      "neutral red stain (540nm readout)",
      "doi:\u00a0https://doi.org/10.1101/2022.02.03.479080"
    ],
    [
      "Bi121",
      "-",
      "183",
      "-",
      "-",
      "rVSV-\u0394G-SARS-CoV-2 S WT (recombinant Vesicular Stomatitis Virus (rVSV)-pseudotyped SARS-CoV-2 S) - Wuhan",
      "Vero E6",
      "-",
      "neutralisaton assay",
      "Promega, Bright-Glo\u2122 Luciferase Assay System",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121",
      "-",
      "1350",
      "-",
      "-",
      "rVSV-\u0394G-SARS-CoV-2 S B1.351 (beta)",
      "Vero E6",
      "-",
      "neutralisaton assay",
      "Promega, Bright-Glo\u2122 Luciferase Assay System",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121",
      "-",
      "259.4",
      "-",
      "-",
      "rVSV-\u0394G-SARS-CoV-2 S B1.1.7 (alpha)",
      "Vero E6",
      "-",
      "neutralisaton assay",
      "Promega, Bright-Glo\u2122 Luciferase Assay System",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121",
      "-",
      "273.3",
      "-",
      "-",
      "rVSV-\u0394G-SARS-CoV-2 S B1.427",
      "Vero E6",
      "-",
      "neutralisaton assay",
      "Promega, Bright-Glo\u2122 Luciferase Assay System",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121",
      "-",
      "999.6",
      "-",
      "-",
      "rVSV-\u0394G-SARS-CoV-2 S Delta",
      "Vero E6",
      "-",
      "neutralisaton assay",
      "Promega, Bright-Glo\u2122 Luciferase Assay System",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121",
      "-",
      "183.8",
      "-",
      "-",
      "rVSV-\u0394G-SARS-CoV-2 S D614G",
      "Vero E6",
      "-",
      "neutralisaton assay",
      "Promega, Bright-Glo\u2122 Luciferase Assay System",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "4-5 log reduction",
      "-",
      "SARS-COV-2 (USA WA1/2020)",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "4-5 log reduction",
      "-",
      "SARS-COV-2 (Hongkong/VM20001061/2020)",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "4-5 log reduction",
      "-",
      "SARS-COV-2 (B.1.167.2 (Delta)",
      "Vero E6",
      "0.05",
      "RT-qPCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "2-3 log reduction",
      "-",
      "SARS-COV-2 (USA WA1/2020)",
      "Vero E6",
      "0.05",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "2-3 log reduction",
      "-",
      "SARS-COV-2 (Hongkong/VM20001061/2020)",
      "Vero E6",
      "0.05",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "2-3 log reduction",
      "-",
      "SARS-COV-2 (B.1.167.2 (Delta)",
      "Vero E6",
      "0.05",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "4-5 log reduction",
      "-",
      "SARS-COV-2 (USA WA1/2020)",
      "HEK-ACE2",
      "0.1",
      "RT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "4-5 log reduction",
      "-",
      "SARS-COV-2 (Hongkong/VM20001061/2020)",
      "HEK-ACE2",
      "0.1",
      "RT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "4-5 log reduction",
      "-",
      "SARS-COV-2 (B.1.167.2 (Delta)",
      "HEK-ACE2",
      "0.1",
      "RT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "2-3 log reduction",
      "-",
      "SARS-COV-2 (USA WA1/2020)",
      "HEK-ACE2",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "2-3 log reduction",
      "-",
      "SARS-COV-2 (Hongkong/VM20001061/2020)",
      "HEK-ACE2",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Bi121 (1:40)",
      "-",
      "-",
      "2-3 log reduction",
      "-",
      "SARS-COV-2 (B.1.167.2 (Delta)",
      "HEK-ACE2",
      "0.1",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "Fractionated Bi121: F0-F8",
      "-",
      "-",
      "F5 = 40% viral inhibition at 6.25ug/ml",
      "-",
      "SARS-CoV-2",
      "Vero E6",
      "0.01",
      "MTT",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.29.477140"
    ],
    [
      "CPC - 0.05% (w/v)",
      "-",
      "-",
      "91.9% - 97% titre reduction",
      "-",
      "SARS-CoV2 (isolate from patient on ship Diamond Princess)",
      "Vero E6 (TMPRSS2) - Japanese Collection of Research Bioresources Cell Bank",
      "90ul CPC with 10ul of virus for 20, 60 and 300seconds",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.27.477964"
    ],
    [
      "CPC - 0.1% (w/v)",
      "-",
      "-",
      "91.9% - 97% titre reduction",
      "-",
      "SARS-CoV2 (isolate from patient on ship Diamond Princess)",
      "Vero E6 (TMPRSS2) - Japanese Collection of Research Bioresources Cell Bank",
      "90ul CPC with 10ul of virus for 20, 60 and 300seconds",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.27.477965"
    ],
    [
      "CPC - 0.3% (w/v)",
      "-",
      "-",
      "91.9% - 97% titre reduction",
      "-",
      "SARS-CoV2 (isolate from patient on ship Diamond Princess)",
      "Vero E6 (TMPRSS2) - Japanese Collection of Research Bioresources Cell Bank",
      "90ul CPC with 10ul of virus for 20, 60 and 300seconds",
      "plaque assay",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.27.477966"
    ],
    [
      "Harringtonine (HT)",
      "-",
      "0.125",
      "70% cells survival nder 1uM HT",
      "-",
      "SARS-CoV-2\u0394N trVLP",
      "Caco-2-N",
      "-",
      "CPE",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.22.477323"
    ],
    [
      "Harringtonine (HT)",
      "-",
      "0.217",
      "-",
      "1.35uM",
      "SARS-CoV-2-WIV04",
      "Vero E6",
      "-",
      "RT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2022.01.22.477323"
    ],
    [
      "Harringtonine (HT)",
      "-",
      "0.101",
      "-",
      "1.35",
      "SARS-CoV-2-Delta 630",
      "Vero E6",
      "-",
      "RT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2022.01.22.477323"
    ],
    [
      "Harringtonine (HT)",
      "-",
      "0.042",
      "-",
      "1.35",
      "SARS-CoV-2-Omicron",
      "Vero E6",
      "-",
      "RT-PCR",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2022.01.22.477323"
    ],
    [
      "Remdesivir",
      "Nanoformulated Remdesivir",
      "-",
      "activity kinetics similar to iv formulations of Remdesivir",
      "-",
      "SARS-CoV-2-nLuc",
      "A549-Ace2",
      "0.02",
      "plaque assay",
      "NanoGlo Luciferase Assay System (Promega) for virus growth / CellTiter-Glo 2.0 Cell Viability Assay (Promega) for cell viability",
      "doi:\u00a0https://doi.org/10.1101/2022.01.21.477258"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.07",
      "active",
      "-",
      "SARS-CoV-2-Omicron (patients isolate with genomic sequence verification for B.1.1.529)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.21",
      "active",
      "-",
      "SARS-CoV2/WA1/2020",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.13",
      "active",
      "-",
      "MA-SARS-CoV2/WA1",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.12",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.23",
      "active",
      "-",
      "SARS-CoV2 beta (B1.617.2)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.17",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.76",
      "active",
      "-",
      "SARS-CoV-2-Omicron (patients isolate with genomic sequence verification for B.1.1.529)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.54",
      "active",
      "-",
      "SARS-CoV2/WA1/2020",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.5",
      "active",
      "-",
      "MA(mouse adapted)-SARS-CoV2/WA1",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.61",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.6",
      "active",
      "-",
      "SARS-CoV2 beta (B1.617.2)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.69",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "10.44",
      "active",
      "-",
      "SARS-CoV-2-Omicron (patients isolate with genomic sequence verification for B.1.1.529)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "10.33",
      "active",
      "-",
      "SARS-CoV2/WA1/2020",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "8.3",
      "active",
      "-",
      "MA-SARS-CoV2/WA1",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "9.6",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      ">10",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "12.79",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "HeLa-ACE2",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.02",
      "active",
      "-",
      "SARS-CoV-2-Omicron (patients isolate with genomic sequence verification for B.1.1.529)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.04",
      "active",
      "-",
      "SARS-CoV2/WA1/2020",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.02",
      "active",
      "-",
      "MA-SARS-CoV2/WA1",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.02",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.12",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.07",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.02",
      "active",
      "-",
      "SARS-CoV-2-Omicron (patients isolate with genomic sequence verification for B.1.1.529)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.05",
      "active",
      "-",
      "SARS-CoV2/WA1/2020",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.02",
      "active",
      "-",
      "MA(mouse adapted)-SARS-CoV2/WA1",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.04",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.03",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "0.02",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "0.25",
      "active",
      "-",
      "SARS-CoV-2-Omicron (patients isolate with genomic sequence verification for B.1.1.529)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "1.12",
      "active",
      "-",
      "SARS-CoV2/WA1/2020",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "0.76",
      "active",
      "-",
      "MA-SARS-CoV2/WA1",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "0.6",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "2.35",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "1.81",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "Vero-TMPRSS2 in presence of PgP inhibitor 2uM",
      "0.025",
      "immunofluorescence",
      "FFU staining for viral N protein with DAPI counterstain",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "-",
      "-",
      "90%-100% viability",
      "all variants above",
      "HeLa-ACE2",
      "-",
      "MTT assay (Roche)",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Remdesivir",
      "-",
      "-",
      "-",
      "90%-100% viability",
      "all variants above",
      "HeLa-ACE2",
      "-",
      "MTT assay (Roche)",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "EIDD-1931",
      "-",
      "-",
      "-",
      "90%-100% viability",
      "all variants above",
      "HeLa-ACE2",
      "-",
      "MTT assay (Roche)",
      "CPE",
      "doi:\u00a0https://doi.org/10.1101/2022.01.17.476685"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.038",
      "active",
      "-",
      "USA-WA1/2020 strain",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.041",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.127",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.0249",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.0212",
      "active",
      "-",
      "SARS-CoV2 lambda (B.1.1.1.37)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.0159",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.0257",
      "active",
      "-",
      "Variant of Interest (VOI) B.1.621 (\u00b5)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.0162",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0154",
      "active",
      "-",
      "USA-WA1/2020 strain",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.007",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0148",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0039",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0033",
      "active",
      "-",
      "SARS-CoV2 lambda (B.1.1.1.37)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0019",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0058",
      "active",
      "-",
      "Variant of Interest (VOI) B.1.621 (\u00b5)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "Remdesivir",
      "-",
      "0.0032",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)",
      "VeroE6 P-gp knockout",
      "0.041",
      "qRT-PCR",
      "-",
      "\u00a0doi:\u00a0https://doi.org/10.1101/2022.01.17.476644"
    ],
    [
      "GS-441524",
      "-",
      "0.76",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7) - patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "GS-441524",
      "-",
      "0.77",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "GS-441524",
      "-",
      "0.9",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "GS-441524",
      "-",
      "0.87",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "GS-441524",
      "-",
      "0.5",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "GS-441524",
      "-",
      "0.81",
      "active",
      "-",
      "SARS-CoV2 GHB-03021/2020-patient isolate close to ancestral Wuhan-Hu-1 2019",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Remdesivir",
      "-",
      "0.077",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7) - patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Remdesivir",
      "-",
      "0.063",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Remdesivir",
      "-",
      "0.074",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Remdesivir",
      "-",
      "not determined",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Remdesivir",
      "-",
      "0.048",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Remdesivir",
      "-",
      "0.052",
      "active",
      "-",
      "SARS-CoV2 GHB-03021/2020-patient isolate close to ancestral Wuhan-Hu-1 2019",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "EIDD-1931",
      "-",
      "2.3",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7) - patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "EIDD-1931",
      "-",
      "1.5",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "EIDD-1931",
      "-",
      "2",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "EIDD-1931",
      "-",
      "3.3",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "EIDD-1931",
      "-",
      "not determined",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "EIDD-1931",
      "-",
      "2.2",
      "active",
      "-",
      "SARS-CoV2 GHB-03021/2020-patient isolate close to ancestral Wuhan-Hu-1 2019",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Molnupiravir",
      "-",
      "3.6",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7) - patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Molnupiravir",
      "-",
      "not determined",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Molnupiravir",
      "-",
      "not determined",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Molnupiravir",
      "-",
      "not determined",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Molnupiravir",
      "-",
      "1.9",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Molnupiravir",
      "-",
      "3.9",
      "active",
      "-",
      "SARS-CoV2 GHB-03021/2020-patient isolate close to ancestral Wuhan-Hu-1 2019",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.28",
      "active",
      "-",
      "SARS-CoV2 alpha (B1.1.7) - patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.14",
      "active",
      "-",
      "SARS-CoV2 beta (B1.351)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.28",
      "active",
      "-",
      "SARS-CoV2 gamma (P1)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.21",
      "active",
      "-",
      "SARS-CoV2 delta (B1.617.2)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.14",
      "active",
      "-",
      "SARS-CoV-2-Omicron ( B.1.1.529)-patient isolate",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Nirmatrelvir",
      "-",
      "0.11",
      "active",
      "-",
      "SARS-CoV2 GHB-03021/2020-patient isolate close to ancestral Wuhan-Hu-1 2019",
      "VeroE6-GFP, Janssen Pharmaceutica+0.5uM CP-100356 (P-gp inhibitor)",
      "0.001",
      "immunofluorescence",
      "CPE",
      "https://doi.org/10.1016/j.antiviral.2022.105252"
    ],
    [
      "Favipiravir",
      "-",
      "not given",
      "80% inbition with 625uM",
      "-",
      "SARS-CoV-2 isolate (hCoV- 19/Turkey/HSGM 302/2020 (Clade GR)); GISAID accession number of EPI_ISL_437313|2020-03-27",
      "Vero E6",
      "0.1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.11.475889"
    ],
    [
      "Camostat mesylate with favipiravir",
      "-",
      "not given",
      ">90% inhibition with 625uM",
      "-",
      "SARS-CoV-2 isolate (hCoV- 19/Turkey/HSGM 302/2020 (Clade GR)); GISAID accession number of EPI_ISL_437313|2020-03-28",
      "Vero E6",
      "0.1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.11.475890"
    ],
    [
      "Umifenovir (repurposed influenza drug)",
      "-",
      "625",
      "-",
      "-",
      "SARS-CoV-2 isolate (hCoV- 19/Turkey/HSGM 302/2020 (Clade GR)); GISAID accession number of EPI_ISL_437313|2020-03-29",
      "Vero E6",
      "0.1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.11.475891"
    ],
    [
      "Umifenovir and favipiravir",
      "-",
      "not given",
      ">90% inhibition with 625uM",
      "-",
      "SARS-CoV-2 isolate (hCoV- 19/Turkey/HSGM 302/2020 (Clade GR)); GISAID accession number of EPI_ISL_437313|2020-03-30",
      "Vero E6",
      "0.1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.11.475892"
    ],
    [
      "Camostat mesylate with umifenovir",
      "-",
      "not given",
      ">95% inhibition with 2500uM",
      "-",
      "SARS-CoV-2 isolate (hCoV- 19/Turkey/HSGM 302/2020 (Clade GR)); GISAID accession number of EPI_ISL_437313|2020-03-31",
      "-",
      "0.1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.11.475893"
    ],
    [
      "Camostat mesylate (repurposed, inhibiton of TMPRSS2)",
      "-",
      "not given",
      ">95% inhibition with 5000uM",
      "-",
      "SARS-CoV-2 isolate (hCoV- 19/Turkey/HSGM 302/2020 (Clade GR)); GISAID accession number of EPI_ISL_437313|2020-03-31",
      "Vero E6",
      "0.1",
      "qRT-PCR",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2022.01.11.475894"
    ],
    [
      "Camostat mesylate",
      "-",
      "59.98 uM",
      "active",
      "-",
      "icSARS-CoV-2-mNG (SARS-CoV-2 Spike-pseudotyped lentivirus with confirmed infectivity as WA1/2020)",
      "ACE2plusC3 cells (A549 cell line transduced to expresss high level of ACE2 and TMPRSS2, enriched A549ACE2/TMPRSS2)",
      "0.1",
      "immunoflorescence staining with anti-NP antibody and DAPI counterstain\nLDH cytotoxicity on post-incubation supernatant",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.31.474593"
    ],
    [
      "EIDD-1931",
      "-",
      "0.84uM",
      "active",
      "-",
      "icSARS-CoV-2-mNG (SARS-CoV-2 Spike-pseudotyped lentivirus with confirmed infectivity as WA1/2020)",
      "ACE2plusC3 cells (A549 cell line transduced to expresss high level of ACE2 and TMPRSS2, enriched A549ACE2/TMPRSS2)",
      "0.1",
      "immunoflorescence staining with anti-NP antibody and DAPI counterstain\nLDH cytotoxicity on post-incubation supernatant",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.31.474594"
    ],
    [
      "Remdesivir",
      "-",
      "0.14uM",
      "active",
      "-",
      "icSARS-CoV-2-mNG (SARS-CoV-2 Spike-pseudotyped lentivirus with confirmed infectivity as WA1/2020)",
      "ACE2plusC3 cells (A549 cell line transduced to expresss high level of ACE2 and TMPRSS2, enriched A549ACE2/TMPRSS2)",
      "0.1",
      "immunoflorescence staining with anti-NP antibody and DAPI counterstain\nLDH cytotoxicity on post-incubation supernatant",
      "-",
      "doi:\u00a0https://doi.org/10.1101/2021.12.31.474595"
    ]
  ]
}